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Abbreviations 
AHP, afterhyperpolarization; 
ALS, amyotrophic lateral sclerosis; 
AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid; 
APV, D-amino-phosphonovalerate; 
ARE, antioxidant-response element;  
ATF-3, activating transcription factor 3; 
BCL2, B-cell lymphoma 2; 
BiP, binding immunoglobulin protein; 
CHMP2B, charged multivesicular body protein 2B 
CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione;  
CSF, cerebrospinal fluid; 
CytC, cytochrome c; 
DHR 123, dihydrorhodamine 123; 
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dsDNA, double strand DNA; 
EAAT2, excitatory amino acid transporter 2; 
ER, endoplasmic reticulum; 
FUS / TLS, fused-in-sarcoma / translated-in-liposarcoma; 
GABA, γ-aminobutyric acid;  
GAPDH, glyceraldehyde 3-phosphate dehydrogenase;  
GC, guanylate cyclase; 
GFAP, glial fibrillary acidic protein; 
GLT-1, glutamate transporter-1; 
GluR2, glutamate receptor subunit 2; 
GSH / GSSG, glutathione reduced and oxidized form; 
GST, glutathione S-transferase; 
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HO-1, heme oxygenase 1; 
IP3R, inositol-1,4,5-trisphosphate receptor; 
Ih, hyperpolarization-activated cationic current; 
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mIPSC, miniature inhibitory postsynaptic current; 
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Nox, NADPH oxidases; 
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ONOO−, peroxynitrite; 
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SOD1, superoxide dismutase 1; 
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UPR, unfolded protein response; 
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Abstract 
 
Oxidative stress of motoneurons is believed to be an important contributor to 
neurodegeneration underlying the familial (and perhaps even the sporadic) form of 
amyotrophic lateral sclerosis (ALS). This concept has generated numerous rodent genetic 
models with inborn oxidative stress to mimic the clinical condition. ALS is, however, a 
predominantly sporadic disorder probably triggered by environmental causes that, upon 
repeated exposure, ultimately evoke motoneuron degeneration. Thus, it is interesting to 
understand how wildtype motoneurons react to strong oxidative stress since this response 
might cast light on the presymptomatic disease stage. The present study used, as a model, 
hypoglossal motoneurons from the rat brainstem slice to investigate how hydrogen peroxide 
could affect synaptic transmission and intrinsic motoneuron excitability in relation to their 
survival. Hydrogen peroxide (1 mM; 30 min) induced an inward current (or membrane 
depolarization) accompanied by an increase in input resistance, augmented firing and 
depressed spontaneous synaptic events. Despite enhanced intracellular oxidative processes, 
there was no early death of motoneurons although most cells became immunopositive for 
ATF-3, a stress related transcription factor. No astroglia damage was observed. In the 
presence of hydrogen peroxide, voltage clamp experiments indicated increased frequency of 
excitatory and inhibitory miniature events, and reduced voltage-gated persistent currents of 
motoneurons. The global effect of this transient oxidative challenge was to depress the input 
flow from the premotoneurons to motoneurons that became more excitable due to a 
combination of enhanced input resistance and impaired spike afterhyperpolarization. Our 
data, therefore, show previously unreported changes in motoneuron activity associated with 
cell distress caused by a transient oxidative insult. 
Furthermore, as a way of comparison with hydrogen peroxide effects, preliminary 
experiments were started to characterize changes in motoneuron electrophysiological 
properties subsequent to application of a nitrosative agent, namely the nitric oxide donor 
sodium nitroprusside (500 µM; 30 min). These data outlined an action of NO distinct from 
the one of hydrogen peroxide, indicating that the cellular mechanisms underlying oxidative 
and nitrosative damage are likely to be different.  
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Introduction 
 
Amyotrophic lateral sclerosis (ALS) is among the most common adult-onset 
neurodegenerative diseases. ALS typically develops between 50 and 60 years of age as a 
relentless, progressive neuromuscular failure, caused by degeneration of both upper 
motoneurons in the motor cortex and lower motoneurons connecting the spinal cord and 
brainstem to skeletal muscle fibers, leading to muscle denervation and atrophy. Initial 
symptoms often present in one motoneuron population, but will spread to contiguous 
motoneuron groups. Although variants of the disease may apparently affect a discrete 
motoneuron population, such as only lower motoneurons, upper motoneurons, or bulbar 
motoneurons (innervating muscles that control speech, chewing, and swallowing), signs of 
both upper and lower motoneuron dysfunction develop in the majority of patients as the 
disease progresses. Certain motoneuron populations are much less vulnerable, specifically 
those in the upper brainstem nuclei that control eye movements and those in Onuf's nucleus 
in the sacral spinal cord controlling the pelvic floor muscles. The rate of disease progression 
varies between individuals and can be influenced by the site of onset, but is usually rapid, 
with an average survival of only 2-3 years from symptom onset. The major cause of death is 
respiratory failure. ALS pathology is characterized by loss of motoneurons with ubiquitinated 
inclusions, abnormal mitochondria, and neurofilament aggregates in surviving motoneurons, 
and glial activation. Riluzole, the only drug currently licensed as a neuroprotective agent for 
ALS, extends life expectancy by only approximately 3 months (Leigh, 2007). 
 
1. Causes of ALS 
The disease cause is unknown in the majority of ALS cases, which are described as being 
sporadic (SALS), although 5-10 % of cases are genetic and are classified as familial (FALS). 
The etiology of SALS is largely unknown, and the worldwide incidence of disease is fairly 
uniform at around 1-2 / 100,000 in most populations (Kurtzke, 1982). The exceptions to this 
are the Western Pacific island of Guam and the Kii peninsula of Japan, where the incidence 
has been much higher, possibly linked to an environmental toxin such as β-methylamino-L-
alanine (Cox et al., 2003). The prevalence of ALS has also been reported to be increased 
among Gulf War veterans (Horner et al., 2003; Kasarskis et al., 2009) and in some groups of 
athletes (Chiò et al., 2005). SALS and FALS are clinically indistinguishable and do not 
usually develop until middle or later life, so identification of genetic cases is not 
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straightforward, as a clear family history needs to be documented. Mutations in several genes 
have now been identified as leading to ALS, and additional loci have also been linked to the 
disease (Valdmanis & Rouleau, 2008). The first gene to be identified as being mutated in 
ALS, which accounts for 10-20 % of autosomal dominant FALS cases, was copper / zinc 
superoxide dismutase (Cu / Zn SOD, SOD1; Rosen et al., 1993). Other genes, mutations of 
which can lead to adult-onset ALS, include fused-in-sarcoma / translated-in-liposarcoma 
(FUS / TLS; Kwiatkowski et al., 2009; Vance et al., 2009), TAR DNA-binding protein 
(TDP-43; Kabashi et al., 2008; Sreedharan et al., 2008), charged multivesicular body protein 
2B (CHMP2B; Parkinson et al., 2006), vesicle-associated membrane protein (synaptobrevin-
associated protein) B (VAPB; Nishimura et al., 2004), and angiogenin (Greenway et al., 
2006), although all of these are less common than SOD1 mutations. Over 140 mutations in 
the 153 amino acids of the SOD1 protein have been described to date and these are spread 
throughout all five exons, as well as a small number in untranslated regions (Orrell, 2000; 
Fig. 1).  
 
Fig. 1. ALS-causing mutations lie throughout the SOD1 polypeptide. (a) Mutations in the 
153-amino-acid superoxide dismutase 1 (SOD1) polypeptide that are known to cause ALS. 
(b) The positions of these mutations in the three-dimensional structure of crystallized human 
SOD1 were highlighted using Rasmol (R. Sayle, Biomolecular Structures Group, 
GlaxoWellcome Research & Development). Mutations are scattered throughout the protein: 
at turns of the β-barrel, within β-sheets of the β-barrel, within the active site channel, at the 
dimer interface, and at copper-coordinating residues in the active site. Some mutated 
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positions are marked with spacing-filling models of the amino-acid side chains. The positions 
of others are simply coloured yellow in the polypeptide chain. The 20 amino acids of the 
carboxyl terminus are truncated in several mutants and are coloured in green. The remaining 
polypeptide backbone is grey (adapted from Cleveland & Rothstein, 2001). 
 
Given the diversity of the physiological functions affected by mutations in these genes, it is 
generally assumed that the disease classified as “ALS” is the result of defects in a variety of 
cellular mechanisms. Identification of SOD1 mutations has enabled development of animal 
and cell culture models, from which much of our understanding of the mechanisms of 
neurodegeneration in ALS has emerged. These include oxidative stress, excitotoxicity caused 
by dysregulation of glutamate signaling, mitochondrial dysfunction, endoplasmic reticulum 
stress, protein aggregation, disruption of the neurofilament network and intracellular 
trafficking along microtubules, involvement of non-neuronal cells neighboring motoneurons, 
and defects in RNA processing. The degeneration leads to motoneuron death through a 
caspase-dependent programmed cell death pathway resembling apoptosis (Sathasivam et al., 
2001; Fig. 2). 
                                     
Fig. 2. Schematic representation of putative major mechanisms responsible for ALS 
neurodegeneration (adapted from Cleveland & Rothstein, 2001). 
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2. ALS animal models 
Mutations of SOD1 are one of the proven causes of ALS in humans, at least in its familial 
form (Rosen et al., 1993; Gurney et al., 1994; Ripps et al., 1995; Wong et al., 1995; 
Prudencio et al., 2009). More than 140 mutations of this enzyme, mostly involving single 
amino acids replacements, have been associated with cases of FALS (Boillée et al., 2006; 
Bergemalm et al., 2006). Murine models incorporating a human mutated hSOD1 gene are, 
thus, important tools to study the mechanisms involved in FALS pathology (Gurney et al., 
1994; Cleveland & Rothstein, 2001; Boillée et al., 2006). Because FALS and SALS cases are 
clinically similar, progress in elucidating the mechanisms underlying FALS may provide 
insight into both forms of the disease. Most work has focused on the SOD1G93A mouse model 
(high expressor line) overexpressing the dominant missense G93A mutation (Gly93 to Ala 
amino acid substitution) of Cu / Zn superoxide dismutase human gene (Gurney et al., 1994). 
These mice develop a disease with a relatively short course and a pathology mainly 
characterized by severe vacuolar degeneration of motoneurons and their processes. A similar 
vacuolar pathology is displayed by mice expressing high levels of SOD1G37R mutants (Wong 
et al., 1995). However, recent work (Bergemalm et al., 2006) has shown that high levels of 
hSOD1 expression can cause artificial loading of SOD1 enzyme in mitochondria and cause 
effects potentially misleading for an understanding of human ALS pathology. Other models 
expressing a lower copy number of the mutant hSOD1 gene and surviving longer include the 
SOD1G93A low expressor mice, which survive 6-7 months (Dal Canto & Gurney, 1997) and 
the SOD1G85R transgenic mice expressing the G85R mutation with GLY85 to arginine amino 
acid substitution (Bruijn et al., 1997; 1998). The homozygous SOD1G85R (line 148) survives 
7.5-8 months (Bruijn et al., 1997) and the heterozygous SOD1G85R survives 10-12 months 
(Williamson & Cleveland, 1999). In these animals, anterior horn cell depletion, atrophy, 
astrocytosis, axonal swellings, and the presence of numerous ubiquitinated Lewy-like bodies 
are the main pathological features, while vacuolar pathology is minimal. These mutants, with 
ALS symptoms more resembling human FALS, may be preferable models for the study of 
this pathogenesis (Jonsson et al., 2004; Bergemalm et al., 2006). Behavioral tests on a strain 
of SOD1G85R homozygous mice (line 148) have shown delayed development of reflex 
responses during the first postnatal week (Amendola et al., 2004; Durand et al., 2006), 
together with an abnormal dendritic branching increasing the surface area of the mutant 
motoneurons (Amendola et al., 2007; Amendola & Durand, 2008) at the same age. In this 
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mutant line, astrocytes seem to be the primary target leading to motoneuron degeneration 
(Bruijn et al., 1997). However, some types of experimental manipulations have been difficult 
in ALS mice because of their innate size limitations. It has been almost impossible, for 
example, to analyze cerebrospinal fluid (CSF) from the ALS mice, even at single time points. 
It has also been very difficult to use therapies that involve repeated administration of 
compounds into the CSF. There is only a single report of pump-mediated delivery of drugs to 
the CSF of the ALS mice, and that approach was intraventricular rather than intrathecal (Li et 
al., 2000); it is likely that intrathecal administration will produce significantly better 
therapeutic levels of compounds at the spinal cord level than will the intraventricular 
approach (Gurney et al., 2000). It has also been difficult to obtain sufficient tissue to perform 
extensive biochemical analyzes, such as investigations of posttranscriptional modifications of 
proteins like SOD1 itself during disease progression. For these reasons, rat models of ALS 
have been developed by expressing a human SOD1 transgene (Nagai et al., 2001; Howland 
et al., 2002; Aoki et al., 2005). Rats that express a human SOD1 transgene with two different 
ALS-associated mutations (G93A and H46R) develop striking motoneuron degeneration and 
paralysis. As in the human disease and transgenic ALS mice, pathological analysis 
demonstrates selective loss of motoneurons in the spinal cords of these transgenic rats. In 
spinal cord tissues, this is accompanied by activation of apoptotic genes triggered by the 
mutant SOD1 protein in vitro and in vivo. These animals provide additional support for the 
proposition that motoneuron death in SOD1-related ALS reflects one or more acquired, 
neurotoxic properties of the mutant SOD1 protein (Nagai et al., 2001). In SOD1G93A rat, 
motoneuron disease depends on high levels of mutant SOD1 expression, increasing from 8-
fold over endogenous SOD1 in the spinal cord of young presymptomatic rats to 16-fold in 
end-stage animals. Disease onset in these rats is early, ≈ 115 days, and disease progression is 
very rapid thereafter with affected rats reaching end-stage on average within 11 days. 
Pathological abnormalities include vacuoles initially in the lumbar spinal cord and 
subsequently in more cervical areas, along with inclusion bodies that stain for SOD1, Hsp70, 
neurofilaments, and ubiquitin. Vacuolization and gliosis are evident before clinical onset of 
disease and before motoneuron death in the spinal cord and brainstem. Focal loss of the 
glutamate excitatory amino acid transporter 2 (EAAT2) in the ventral horn of the spinal cord 
coincides with gliosis, but it appears before motoneuron / axon degeneration. At end-stage 
disease, gliosis increases and EAAT2 loss in the ventral horn exceeds 90 %, suggesting a role 
for this protein in the events leading to cell death in ALS (Howland et al., 2002). According 
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to Lladó et al. (2006), facial and hypoglossal motoneurons in the mutant SOD1G93A rats 
(Howland et al., 2002) appear to be spared, especially when compared with the 45 % loss of 
C3-C5 cervical motoneurons. The loss of trigeminal motoneurons is also very modest (12 
%). Interestingly, Haenggeli and Kato (2002) have observed a significant loss of 
motoneurons in the trigeminal, facial, and hypoglossal motor nuclei with sparing of the 
motoneurons in the oculomotor / trochlear nuclei when studying the SOD1G93A mouse. They 
have pointed out that these findings are consistent with those seen in human ALS (DePaul et 
al., 1988). This suggests that the rat model differs not only from the murine counterpart, but 
also from some cases of human ALS. One possible explanation for these differences is that 
the rapidity of motor decline from onset of disease to end-stage is significantly shorter in the 
rat and thus the sparing of cranial nuclei may be more apparent than real since the disease 
progresses from hindlimb to forelimb paresis and to respiratory decline too rapidly for the 
cranial nuclei to undergo a more delayed degeneration. The presence of vacuolar pathology 
observed within the neuropil of the cranial nuclei suggests that the typical SOD1G93A 
pathology is already present in the region, even if motoneurons have not yet degenerated 
(Lladó et al., 2006). 
 
3. Evidence for oxidative stress in ALS 
Oxidative stress arises from an imbalance between the production of reactive oxygen species 
(ROS) and the ability of the system to remove or repair the damage. Cellular ROS arise as 
by-products of aerobic metabolism (Coyle & Puttfarcken, 1993; Lenaz, 1998; Halliwell & 
Gutteridge, 1999), mostly due to leakage of electrons from the mitochondrial respiratory 
chain, resulting in incomplete reduction of molecular oxygen during oxidative 
phosphorylation, to produce the superoxide radical anion (O2·−) and hydrogen peroxide 
(H2O2). A small proportion of cellular ROS is produced by other cellular oxidative enzymes, 
including xanthine oxidase in the cytoplasm and the oxidase activity of the cytochrome P450 
system in the endoplasmic reticulum. Free radicals such as superoxide and nitric oxide (NO·) 
are also produced as second messengers, particularly by immune cells. Neither superoxide 
nor hydrogen peroxide is highly reactive, but each one undergoes further reaction to produce 
more potent oxidants. Superoxide reacts rapidly with nitric oxide, a weak oxidant produced 
by nitric oxide synthase (NOS), to produce peroxynitrite (ONOO−; Pryor & Squadrito, 1995; 
Beckman & Koppenol, 1996), whereas hydrogen peroxide slowly decomposes to the highly 
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reactive hydroxyl radical (·OH) in a process that can be catalyzed by reduced metal ions such 
as Fe2+ in the Fenton reaction (Fig. 3).  
                             
Fig. 3. Production of reactive oxygen species. Incomplete reduction of molecular oxygen 
during oxidative phosphorylation and other oxidative reactions leads to production of 
superoxide radicals (O2·−) and hydrogen peroxide (H2O2). Reaction between superoxide and 
nitric oxide (NO) produces peroxynitrite (ONOO−). Hydrogen peroxide is converted to 
hydroxyl radical (.OH) by cytosolic transition metal cations in the Fenton reaction. ROS are 
shown in red (adapted from Barber et al., 2006). 
 
Both peroxynitrite and hydroxyl radicals are highly reactive oxidizing agents, capable of 
damaging proteins, lipids, and DNA. Such a damage includes changing protein 
conformation, altering cellular membrane dynamics by oxidation of unsaturated fatty acids, 
and alterations in DNA and RNA species (Fig. 4).  
                            
Fig. 4. Sources of reactive oxygen species and their targets. ROS are produced during 
oxidative phosphorylation in mitochondria, by oxidative enzymes including cytochrome 
P450 in the endoplasmic reticulum, and by xanthine oxidase (XO) and reduced metal ions in 
the cytosol. Cellular targets attacked by ROS include DNA, proteins, membrane lipids, and 
mitochondria (adapted from Barber et al., 2006). 
 
Multiple pathological studies have reported evidence of increased oxidative stress in ALS 
postmortem tissue compared to control samples. Elevated protein carbonyl levels have been 
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shown in the spinal cord (Shaw et al., 1995) and motor cortex (Ferrante et al., 1997) from 
SALS cases, and increased 3-nitrotyrosine levels, a marker for peroxynitrite-mediated 
damage, are found within spinal cord motoneurons in both SOD1-FALS and SALS patients 
(Abe et al., 1995; Beal et al., 1997). Immunoreactivity to the brain and endothelial forms of 
NOS, but not the inducible form, is also elevated in ALS motoneurons relative to controls 
(Abe et al., 1997), suggesting alterations in reactive nitrogen species (RNS) as well as ROS. 
Markers for lipid oxidation are detected in spinal cord from SALS patients, but are absent in 
control spinal cords (Shibata et al., 2001). Levels of 8-hydroxy-2′-deoxyguanosine (8-
OHdG), a marker of oxidized DNA, are elevated in whole cervical spinal cord from ALS 
patients (Fitzmaurice et al., 1996) and are most prominent within the ventral horn (Ferrante 
et al., 1997). Studies using CSF from ALS patients enable measurement of oxidative stress 
markers at earlier disease stages, rather than simply looking at the end-stage. Such studies 
have reported elevated levels of 8-OHdG (Bogdanov et al., 2000; Ihara et al., 2005), 4-
hydroxynonenal (a marker of lipid peroxidation; Smith et al., 1998; Simpson et al., 2004), 
and ascorbate free radical (Ihara et al., 2005) in CSF samples from ALS patients. Increased 
3-nitrotyrosine levels have also been measured in ALS patient CSF (Tohgi et al., 1999), 
although a subsequent study has shown 3-nitrotyrosine to be elevated in CSF from a minority 
of ALS patients only, and the mean level is not significantly different from that found in 
control CSF samples (Ryberg et al., 2004). Transgenic mouse and cell culture models of 
ALS based on mutant SOD1 recapitulate the oxidative damage to protein, lipid, and DNA 
observed in the human disease (Ferrante et al., 1997b; Andrus et al., 1998; Liu et al., 1998; 
Liu et al., 1999; Cookson et al., 2002; Poon et al., 2005; Casoni et al., 2005; Zimmerman et 
al., 2007; Barber et al., 2009), with mutant SOD1 being one of the most severely oxidized 
proteins identified (Andrus et al., 1998). 
 
4. Sources of oxidative stress in ALS 
Since the upstream cause of the disease is unknown, researchers are limited to working on 
the pathogenethic mechanisms implicated in disease progression. This has led to a debate as 
to whether oxidative stress is the primary cause of degeneration or whether it is merely a 
consequence of some other toxic insult. One of the few clearly identified risk factors for 
developing ALS is age, with few cases being diagnosed before the age of 50. ROS 
production is known to increase with age, primarily due to increased leakage from the 
mitochondrial respiratory chain, and is believed to be a major cause of aging (Beal, 2002; 
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Lenaz et al., 2002; Genova et al., 2004). Although this is unlikely to be the sole cause of 
disease initiation, in some cases it may be what tips the homeostatic control mechanisms 
from coping with a toxic insult into a cycle of cellular injuries that result in motoneuron 
degeneration. The identification of SOD1 mutations has, therefore, revealed a clear 
association between oxidative stress and disease onset. Several mechanisms for mutant 
SOD1 toxicity have been proposed based on altered dismutase activity: (1) loss of dismutase 
function leading to increased levels of superoxide, which can react with nitric oxide to 
produce peroxynitrite (Beckman et al., 1993; Deng et al., 1993); (2) a dominant negative 
mechanism in which the mutant SOD1 protein not only is inactive, but also inhibits the 
function of normal SOD1 expressed by the normal allele (Rosen et al., 1993); or (3) 
increased SOD1 activity leading to increased hydrogen peroxide and hydroxyl radical levels 
(Rosen et al., 1993). However, subsequent investigations have revealed that the mechanism 
for mutant SOD1 toxicity is not so simple. Although some mutations do reduce the dismutase 
activity of SOD1 (such as A4V and G85R; Borchelt et al., 1994), other mutants (such as 
G37R and G93A) retain full dismutase activity (Borchelt et al., 1994; Yim et al., 1996). 
Additionally, a SOD1 knockout mouse does not develop ALS (Reaume et al., 1996), and 
increasing or decreasing levels of wild-type SOD1 also has no effect on mutant SOD1-
related ALS (Bruijn et al., 1998). It is, therefore, now widely accepted that loss of SOD1 
dismutase activity is not sufficient to cause disease and that the mutated SOD1 is toxic 
through an unknown gain of function. A variety of aberrant oxidative reactions catalyzed by 
mutant SOD1 have been proposed to contribute to this new toxic function (Fig. 5). These 
generally assume that mutated SOD1 has a more open conformation than the wild-type 
protein, enabling substrates other than superoxide to enter the active site and react with the 
copper and zinc ions contained within. Normally, SOD1 catalyzes dismutation of superoxide 
radicals to hydrogen peroxide and oxygen in a two-step redox reaction involving reduction 
and reoxidization of the copper ion in the active site of the dimeric protein. However, SOD1 
has also been reported to act as a peroxidase, either catalyzing the reverse of its normal 
dismutase reaction or using the hydrogen peroxide produced in the dismutation as a substrate 
to produce hydroxyl radicals through the Fenton reaction (Yim et al., 1990; Yim et al., 
1993). 
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Fig. 5. Summary of SOD1 activity. (1) Normal dismutase activity of SOD1, converting 
superoxide into oxygen and hydrogen peroxide. (2) Peroxidase activity catalyzing the reverse 
of the dismutase reaction or using the hydrogen peroxide produced in the dismutation as a 
substrate to produce hydroxyl radicals through the Fenton reaction. (3) Superoxide reacts 
with nitric oxide to produce peroxynitrite, which is used by SOD1 to cause nitration of 
tyrosine residues within proteins. (4) Zinc-deficient SOD1 is reduced by reducing agents 
other than superoxide (e.g., ascorbate and glutathione). The reduced SOD1-Cu+ can produce 
superoxide in the reverse of its usual dismutase reaction, which reacts with nitric oxide 
within the active site to produce peroxynitrite, which then causes tyrosine nitration (adapted 
from Barber & Shaw, 2010). 
 
The ALS-causing mutants SOD1A4V and SOD1G93A are reported to have enhanced peroxidase 
activity both in vitro and in vivo (Wiedau-Pazos et al., 1996; Roe et al., 2002), although 
another study has found no differences between the peroxidase activity of wild-type SOD1 
and the same SOD1 mutants (Singh et al., 1998), casting doubt on the contribution of 
peroxidase activity to mutant SOD1-mediated ALS. Alternatively, many ALS-associated 
SOD1 mutants have been reported to show altered zinc binding (Smith & Lee, 2007), and the 
geometry of zinc-deficient SOD1 allows reducing agents other than superoxide (for example, 
ascorbate and glutathione) to react rapidly with the oxidized Cu2+ at the active site (Lyons et 
al., 1996; Crow et al., 1997; Roberts et al., 2007). It has been proposed that the reduced 
SOD1-Cu+ can produce superoxide in the reverse of its usual dismutase reaction, which 
reacts with nitric oxide within the active site to produce peroxynitrite (Estevez et al., 1999), 
which then causes tyrosine nitration. In support of this, zinc deficiency in SOD1G93A mice 
accelerates disease progression, whereas moderate zinc supplementation delays death 
(Ermilova et al., 2005). However, if peroxynitrite contributed significantly to disease 
progression, it would be predicted that decreasing nitric oxide level, which is required for 
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production of peroxynitrite, would alter the disease course. Deletion of either neuronal or 
inducible nitric oxide synthase has been reported to have no effect on disease progression of 
mutant SOD1 mice (Facchinetti et al., 1999; Son et al., 2001; Bruijn et al., 2004), casting 
doubt on the role of zinc deficiency in mutant SOD1 pathogenesis. Other studies have shown 
that enzymatically inactive SOD1 is also capable of causing motoneuron degeneration; 
depleting copper loading into SOD1 by deletion of the copper chaperone for SOD1 leads to 
marked reduction of SOD1 activity, but has no effect on disease onset, progression, or 
pathology of SOD1G93A, SOD1G37R, or SOD1G85R mutant mice (Subramaniam et al., 2002). 
Similarly, abolishing the copper-binding site by mutating the four histidine residues that hold 
the copper ion in the active site (including the two disease-causing mutations H46R and 
H48Q, which have previously been described in patients) produces a completely inactive 
protein, but still causes motoneuron disease similar to other mouse models of ALS (Wang et 
al., 2003). This suggests that mutant SOD1 may induce oxidative stress via an unknown 
mechanism beyond its own catalytic activity.  
Microarray studies of motoneuronal cells expressing mutant SOD1 report down-regulation of 
genes involved in the antioxidant response, including the transcription factor Nrf2 (nuclear 
erythroid 2-related factor 2), several members of the glutathione S-transferase family, and 
two peroxiredoxins (Kirby et al., 2005). Reduced Nrf2 messenger RNA (mRNA) and protein 
expression has more recently been reported in spinal cord neurons from ALS patients 
(Sarlette et al., 2008). Activation of Nrf2 leads to its translocation from the cytoplasm to the 
nucleus, where it interacts with the antioxidant-response element (ARE) enhancer sequence 
to increase expression of proteins involved in antioxidant defense systems (Nguyen et al., 
2009; Fig. 6). Nrf2 is not only involved in inducible gene expression in response to elevated 
oxidative stress, but is also responsible for low-level constitutive activation of the ARE, 
driving the basal expression of antioxidant enzymes in unstressed conditions (Nguyen et al., 
2009). The promoter region of the Nrf2 gene itself contains an ARE sequence, so Nrf2 may 
regulate its own expression levels (Kwak et al., 2002); activation of Nrf2 leads to increased 
Nrf2 production, thereby enlarging the cytosolic pool of Nrf2 available for future activation. 
Although it is currently unclear how Nrf2 expression comes to be down-regulated in ALS 
patients, it should be noted that cellular Nrf2 levels decline by over 50% in old rats (24 
months) relative to young rats (3 months; Suh et al., 2004). Given that increased age is one of 
the major known risk factors for developing ALS, it seems conceivable that the 
mechanism(s) involved in the age-related down-regulation of Nrf2 may also contribute to the 
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down-regulation observed in ALS patients. Down-regulation of Nrf2 expression in ALS may 
reduce the cell's ability to remove ROS generated through normal cellular metabolism, 
resulting in a gradual increase in oxidative stress over time. These findings suggest that 
increasing Nrf2 activity may represent a novel therapeutic goal.  
                            
Fig. 6. Nrf2-ARE signaling pathway. Nrf2 is held in the cytoplasm by Keap1. Upon 
activation, Keap1 releases Nrf2, which translocates to the nucleus and binds to the ARE, 
thereby increasing expression of antioxidant proteins such as glutathione S-transferase 
(GST), NAD(P)H:quinone oxidoreductase 1 (NQO1), and heme oxygenase 1 (HO-1). 
Reduced Nrf2 mRNA and protein expression in motoneurons may contribute to the increased 
oxidative stress observed in ALS (adapted from Barber & Shaw, 2010). 
 
A novel mechanism through which mutant SOD1 might lead to ALS via microglia has 
recently been described (Harraz et al., 2008; Boillée & Cleveland, 2008). Although 
expression of mutant SOD1 restricted to microglia is not sufficient to induce motoneuron 
degeneration in mice, wild-type microglia slows motoneuron loss and disease progression in 
mice expressing mutant SOD1, suggesting that microglia may not contribute to disease onset, 
but does influence disease progression (Beers et al., 2006; Boillée et al., 2006). A 
mechanism for the role of microglial mutant SOD1 has been reported, whereby mutant SOD1 
increases microglial superoxide production by NADPH oxidases (Nox). Nox enzymes are 
transmembrane proteins that, upon activation, reduce oxygen to superoxide (Bedard & 
Krause, 2007). They have important roles in host defense, inflammation, cellular signaling, 
gene expression, cell growth and senescence, and cell death. However, increased Nox 
activity can be pathogenic, and Nox2 is up-regulated in both SALS patients and SOD1G93A 
mutant mice, and deletion of either Nox1 or Nox2 extends survival in SOD1G93A mice (Wu et 
al., 2006; Marden et al., 2007). SOD1 has recently been reported to stabilize Rac1-GTP in 
the activated Nox2 complex, enabling the Nox2 complex to produce superoxide and other 
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ROS derived from superoxide (Fig. 7). Mutant SOD1 is found to lock Rac1 in its active, 
GTP-bound form, thereby prolonging Nox2 activation and increasing ROS production, which 
in turn causes damage to nearby neurons (Harraz et al., 2008; Boillée & Cleveland, 2008). 
Although this mechanism neatly fits the available data for a toxic gain of function in mutant 
SOD1 exerting neurotoxic effects through microglia, it should be noted that enzymatically 
inactive demetallated SOD1 is incapable of binding Rac1, suggesting that this mechanism 
may not be common to all ALS-causing SOD1 mutations. 
                            
Fig. 7. Role of SOD1 in ROS production by Nox2 in activated microglial cells. In resting 
microglia, inactive Nox2 is membrane bound and phox subunits, Rac1-GDP, and SOD1 are 
all cytosolic. In activated microglia, Nox2 becomes activated by phosphorylated phox 
subunits and Rac1-GTP, resulting in production of superoxide. SOD1 has recently been 
shown to stabilize Rac1-GTP in the activated complex, and mutant SOD1 locks Rac1 in its 
active, GTP-bound form, thereby prolonging Nox2 activation and increasing ROS 
production, which in turn causes damage to nearby neurons (adapted from Barber & Shaw, 
2010). 
 
5. Cross talk between oxidative stress and other pathogenic mechanisms 
The pathogenic processes involved in ALS are complex, multifactorial, and incompletely 
understood. What is clear is that motoneuron death occurs not as the result of a single insult, 
but rather through a combination of mechanisms including not only oxidative stress, but also 
excitotoxicity, mitochondrial dysfunction, endoplasmic reticulum stress, protein aggregation, 
cytoskeletal dysfunction, involvement of non-neuronal cells, and defects in RNA processing 
and trafficking. Given the complexity of the disease it is therefore not surprising that 
dissecting cause and effect is not a simple matter. Oxidative stress, whether as a primary 
cause of disease or a secondary consequence, has been implicated in many of these processes 
(Fig. 8). 
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Fig. 8. Oxidative stress can exacerbate other neurodegenerative mechanisms in ALS. (1) 
Glutamate excitotoxicity increases intracellular calcium levels, which are buffered by 
mitochondria leading to increased ROS production. ROS can then inhibit glutamate uptake 
into glial cells, thereby increasing extracellular glutamate levels. (2) The high energy 
demands of the motoneuron are met by mitochondria, but the leaky respiratory chain means 
that ROS are also produced. (3) Prolonged activation of the unfolded protein response in the 
endoplasmic reticulum increases ROS production. (4) Aberrant oxidative reactions catalyzed 
by mSOD1 increase production of the highly reactive peroxynitrite and hydroxyl radicals, 
causing nitration and aggregation of proteins including mSOD1 itself. (5) ROS can attack 
neurofilament subunits, causing dityrosine cross-link formation and aggregation of 
neurofilament subunits. Zinc binding to neurofilaments could deplete zinc binding to 
mSOD1, leading to aberrant SOD1 activity and ROS production. (6) ROS can also cross the 
cell membrane and activate microglia, which respond by releasing cytokines and further 
ROS. The numbering is for illustrative purposes only and does not imply any particular order 
(adapted from Barber & Shaw, 2010). 
 
5.1 Glutamate-mediated excitotoxicity 
Over the past decade, studies have suggested a potential role for glutamate excitotoxicity in 
the pathogenesis of ALS. Glutamate is the major excitatory neurotransmitter released from 
presynpatic nerve terminals, with subsequent diffusion across the synaptic cleft and 
activation of specific postsynaptic receptors, particularly the ionotropic N-methyl-D-
aspartate (NMDA) receptors and α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid 
(AMPA) receptors. The excitatory signal is terminated upon removal of glutamate from the 
synaptic cleft by specific glutamate reuptake transporters located on both neurons and 
astrocytes (Heath & Shaw, 2002). Excitotoxicity occurs when the balance between release 
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and reuptake of glutamate is disturbed, resulting in increased synaptic glutamate 
concentrations and excessive stimulation of glutamate receptors (Heath & Shaw, 2002). A 
significant reduction in the expression of EAAT2, the main astrocytic glutamate transporter, 
is reported in the motor cortex and spinal cord of ALS patients, with oxidative reactions 
inactivating EAAT2 (Rothstein et al., 1995). Reduced expression of GLT-1 (glutamate 
transporter-1, equivalent to human EAAT2) and decreased function of the Na+-dependent 
glutamate transporters on astrocytes have also been reported in the transgenic SOD1 mouse 
models (Bruijn et al., 1997). Recently, activation of caspase-1, which normally inhibits the 
EAAT2 transporter, is found in the SOD1 mouse model prior to onset of motoneuron 
degeneration and clinical features of ALS (Gibb et al., 2007). However, the loss of EAAT2 
appears to be a delayed event in motoneuron degeneration rather than being a primary cause. 
Other mechanisms, particularly SOD1 aggregation and caspase-3 activation, may seem to be 
more important (Bruijn et al., 1997; Guo et al., 2003).  
Turning to postsynaptic processes, increased expression of the NMDA receptor, permeable to 
influx of Na+ and Ca2+, along with expression of AMPA receptors containing an unedited 
GluR2 subunit, have been reported in ALS (Williams et al., 1997; Van Damme et al., 2002). 
The GluR2 subunit regulates AMPA receptors Ca2+ permeability and absence of this subunit 
increases Ca2+ permeability of these receptors (Hollmann et al., 1991). Moreover, the clinical 
benefit of riluzole, an inhibitor of glutamate release, in ALS patients lends further support for 
glutamate-mediated excitotoxicity. A number of cell-specific features of motoneurones may 
render them vulnerable to glutamate toxicity. First, motoneurones preferentially express 
AMPA receptors lacking the functional GluR2 subunit and thereby rendering them more 
permeable to Ca2+ influx (Williams et al., 1997; Van Damme et al., 2002). Secondly, 
motoneurones vulnerable to degeneration lack the intracellular expression of Ca2+ binding 
proteins parvalbumin and calbindin, both required to buffer intracellular Ca2+. Recently, 
increased expression of the inositol 1,4,5-triphosphate receptor 2 (ITPR2) gene is reported in 
ALS (van Es et al., 2007). The ITPR2 is involved in glutamate-mediated neurotransmission, 
with stimulation of glutamate receptors resulting in binding of inositol 1,4,5-triphosphate to 
ITPR2, which subsequently increases intracellular calcium, and ultimately leads to apoptosis. 
Regarding the cross talk between oxidative stress and excitotoxicity, exposure to ROS has 
been demonstrated to be sufficient to reduce glutamate uptake through glutamate transporters 
on both glial and neuronal cells (Volterra et al., 1994; Trotti et al., 1996, 1998; Rao et al., 
2003). Furthermore, increased calcium uptake into motoneuron mitochondria, following 
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AMPA or kainate application, triggers increased ROS generation (Carriedo et al., 2000). 
AMPA / kainate-treated motoneurons release these ROS into the extracellular milieu at 
concentrations sufficient to induce oxidation and disrupt glutamate uptake in neighboring 
astrocytes, thus creating a vicious cycle of increasing oxidative stress and excitotoxicity that 
ultimately leads to motoneuron degeneration (Rao et al., 2003; Rao & Weiss, 2004). 
 
5.2 Mitochondrial dysfunction 
Numerous studies have focused on the role of the mitochondrion in the pathogenesis of ALS. 
Evidence of mitochondrial dysfunction in ALS patients includes clusters of abnormal 
mitochondria and morphological defects identified within mitochondria of skeletal muscles 
and intramuscular nerves in human SALS cases (Afifi et al., 1966; Atsumi, 1981). In such 
cases biochemical analyses have delineated defects in the respiratory chain complexes I and 
IV in muscle (Wiedemann et al., 1998), and elevated levels of mitochondrial calcium (Siklos 
et al., 1996) in muscle and spinal cord. In ALS mice, the main morphological evidence for 
mitochondrial pathology is the presence of vacuolated mitochondria (for example, in the 
G93A and G37R transgenic lines). In the SOD1G93A mice, mitochondrial vacuoles derived 
from a detachment between the inner and the outer membrane (Higgins et al., 2003) appear 
early, and drastically increase in number and volume as the disease progresses (Kong & Xu, 
1998; Bendotti et al., 2001; Sasaki et al., 2004).  
In vitro and in vivo studies further point to mitochondrial defects in ALS mice. The 
expression of mutant SOD1 in neuronal cell lines or in cultured primary motoneurons 
depolarizes mitochondria (Jung et al., 2002; Rizzardini et al., 2006), impairs calcium 
homeostasis (Damiano et al., 2006) and reduces ATP production (Menzies et al., 2002). 
Similarly, SOD1G93A mice show reduced respiratory chain activity and reduced ATP 
synthesis that increase in severity with disease progression. Whether mitochondrial 
dysfunction and pathology represent primary or secondary pathological events is unknown, 
as mitochondrial abnormalities can both result from and cause oxidative toxicity. In either 
circumstance, the pathological mitochondria could mediate cell death by releasing calcium 
into the cytoplasm, producing inadequate levels of ATP and triggering apoptosis (Fig. 9 a). It 
is likely that the mitochondrial function modifies the course of motoneuron degeneration. In 
ALS mice, inhibition of manganese superoxide dismutase (a mitochondrial dismutase) 
accelerates disease progression. Conversely, the disease is slowed by interventions that 
improve mitochondrial function - for example, creatine, which inhibits the opening of the 
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mitochondrial transition pore, and minocycline, which blocks the egress of cytochrome c 
(Klivenyi et al., 1999; Zhu et al., 2002). Several observations have indicated that mutant 
SOD1 could directly damage mitochondria. It is evident that a fraction of SOD1 is localized 
to the mitochondrion (Higgins et al., 2002; Mattiazzi et al., 2002; Okado-Matsumoto & 
Fridovich, 2002; Pasinelli et al., 2004; Liu et al., 2004). In vitro studies of differentially 
targeted SOD1 reveal that mutant SOD1 more potently triggers cell death when localized to 
mitochondria where it forms intra-mitochondrial protein aggregates (Takeuchi et al., 2002; 
Fig. 9 b).  
 
Fig. 9. The mitochondrion as a target for mutant SOD1. Long considered a cytoplasmic 
protein, SOD1 also localizes to the mitochondrion, although its precise localization is not 
fully defined. (a) Mutant SOD1 forms insoluble aggregates that could directly damage the 
mitochondrion through: swelling, with expansion and increased permeability of the outer 
membrane and intermembrane space, leading to release of cytochrome c (CytC) and caspase 
activation; inhibition of the translocator outer membrane (TOM) complex, preventing 
mitochondrial protein import; and aberrant interactions with mitochondrial proteins such as 
BCL2. (b) Aggregates of mutant SOD1 and BCL2 are found specifically in spinal cord but 
not liver mitochondria, a finding that might relate to the motoneuronal specificity of mutant 
SOD1 phenotypes. Codeposition of mutant SOD1 with BCL2 might eliminate BCL2 
function, disrupt the mitochondrial membrane, deplete energy, deregulate mitochondrial 
bioenergetics and activate the mitochondrial apoptotic pathway (WT, wildtype; adapted from 
Pasinelli & Brown, 2006). 
 
Several interlocking mechanisms explain how mutant SOD1 impairs mitochondria from 
within. In SOD1G93A mice, mutant SOD1 colocalizes with cytochrome c and the peroxisomal 
membranes associated with the vacuoles (Higgins et al., 2003). Therefore, mutant SOD1 
could be involved in fusing the peroxisomes and the outer mitochondrial membrane, a 
process that could form pores in the mitochondrial membrane allowing for the release of 
cytochrome c and the initiation of an apoptotic cascade. A second hypothesis is that mutant 
SOD1 is selectively recruited to the outer mitochondrial membrane, where it forms 
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aggregates that slowly disrupt the protein translocation machinery (the translocator outer 
membrane complex, TOM) of the mitochondrion and limits the import of functional proteins 
into the mitochondrion (Liu et al., 2004). Two studies suggest that mutant SOD1 is 
selectively recruited to mitochondria in affected tissues only (Pasinelli et al., 2004; Liu et al., 
2004). It has, therefore, been proposed that the selective loss of TOM function in spinal cord 
mitochondria might form the basis for the tissue specificity of ALS. Finally, mutant SOD1 
aggregates could damage the mitochondrion through abnormal interaction with other 
mitochondrial proteins such the anti-apoptotic protein BCL2 (Pasinelli et al., 2004). A recent 
study challenges the notion of a toxic mitochondrial mutant SOD1, suggesting that 
mitochondrial loading of mutant SOD1 is simply the result of overexpression of the mutant 
SOD1 that normally would not be associated with mitochondria (Bergemalm et al., 2006). 
 
5.3 Endoplasmic reticulum stress and unfolded protein response 
The endoplasmic reticulum (ER) is the site of translation, folding, and transport of membrane 
proteins and secreted proteins. In normal cells, approximately 30 % of newly synthesized 
proteins are misfolded (Schubert et al., 2000), some of these proteins are refolded to have 
correct structures, assisted by ER chaperones such as the binding immunoglobulin protein 
BiP, whereas the other remain misfolded, accumulate in ER, and cause ER stress (Ellgaard et 
al., 1999). Under such ER stress condition, an adaptive self-defense response named 
unfolded protein response (UPR) is triggered to decrease the load of misfolded proteins. 
Several cellular conditions such as high demand for protein secretion (Gass et al., 2002; 
Lipson et al., 2006), viral infection (Isler et al., 2005), deprivation of nutrient / oxygen (Lee, 
1992; Feldman et al., 2005), and missense mutations (Bartoszewski et al., 2008; Ito & 
Suzuki, 2009) enhance protein misfolding and lead to severe ER stress and overwhelming 
accumulation of unfolded or misfolded proteins that causes fatal ER stress. In ALS 
pathogenesis, the ER stress theory has recently emerged. Studies with tissue samples from 
ALS patients and in vivo experiments indicate the involvement of ER stress in ALS (Kikuchi 
et al., 2006; Nagata et al., 2007). In the spinal cord neurons of SALS patients and SOD1G93A 
mice, levels of ER stress-related proteins are upregulated (Kikuchi et al., 2006; Nagata et al., 
2007). ER-stress responses have been reported to be selectively up-regulated in vulnerable 
motoneuron populations, at presymptomatic ages, in three different mutant SOD1 transgenic 
mouse models (Saxena et al., 2009). Furthermore, mutations in vesicle-associated membrane 
protein-associated protein B (VAPB), which has a key role in the UPR, have been shown to 
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lead to ALS in a small proportion of FALS cases (Nishimura et al., 2004). Another intriguing 
hypothesis is that exacerbation of ER stress may be part of the toxic gain of function of 
mutant SOD1. Indeed, mutant, but not wild-type, SOD1 forms highmolecular-weight 
aggregates and interacts with BiP in the ER of spinal cord motoneurons (Kikuchi et al., 
2006), and mutant SOD1 interacts with the protein Derlin-1 (involved in the ER-associated 
protein degradation pathway) in mouse neuronal tissue, leading to ER stress-mediated cell 
death through apoptosis-stimulating kinase-1 (Nishitoh et al., 2008). 
In case of sustained ER stress (for instance, accumulation of misfolded proteins; see above), 
the ER itself can become a source of oxidative stress. During disulfide bond formation (part 
of the protein folding function of the ER), electrons are passed from thiol groups on the 
protein substrates to Ero1 (the protein Ero1, together with protein disulfide isomerase, PDI, is 
essential, in eukaryotic cells, for the disulfide bond formation supported by ER) and finally to 
molecular oxygen, resulting in the generation of ROS (Tu & Weissman, 2004). Unstable 
disulfide bonds are reduced by glutathione in a reaction also catalyzed by Ero1, thereby both 
depleting cellular reserves of reduced glutathione and increasing the number of thiol groups 
available for disulfide bond formation with the concomitant increase in ROS (Cuozzo & 
Kaiser, 1999). Activation of the UPR increases Ero1 expression, which may explain why 
sustained ER stress and prolonged activation of the UPR lead to increased production of ROS 
(Haynes et al., 2004). 
 
5.4 Protein aggregation 
The presence of protein aggregates is a pathological feature common to many 
neurodegenerative diseases, including ALS, although whether they play a role in disease 
pathogenesis, or are harmless by-products, or represent a defense mechanism by 
sequestration of harmful intracellular proteins is not known (Caughey & Lansbury, 2003; 
Ross & Poirier, 2004, 2005). A variety of protein aggregates has been described in ALS, the 
most common of which is the ubiquitinated inclusion, so named because they immunostain 
positively for ubiquitin (Leigh et al., 1988; Wood et al., 2003). One of the major protein 
constituents of ubiquitinated inclusions in ALS is TDP-43 (Neumann et al., 2006; Arai et al., 
2006). Mutant SOD1 is also a major constituent of inclusions in SOD1-linked FALS cases 
(Shibata et al., 1996, 1996b; Chou et al., 1996) and is found in inclusions in mutant SOD1 
transgenic mice (Bruijn et al., 1997, 1998; Johnston et al., 2000; Watanabe et al., 2001) and 
cell culture models (Durham et al., 1997; Lee et al., 2002). Oxidative damage to both mutant 
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and wild-type SOD1 causes dissociation of SOD1 dimers to monomers and subsequent 
aggregation (Rakhit et al., 2004). Because aberrant oxidative reactions catalyzed by metal-
bound SOD1 mutants cause oxidative damage to SOD1 itself (Hodgson & Fridovich, 1975; 
Yim et al., 1990; Andrus et al., 1998), it has been proposed that such oxidative damage could 
lead to aggregation of mutant SOD1 (Valentine & Hart, 2003). Alternatively, SOD1 mutants 
with reduced metal ion binding or demetallated wild-type SOD1 are less stable than 
metallated SOD1 (Rodriguez et al., 2002) and show increased propensity to aggregate 
(Rakhit et al., 2002). A general mechanism for SOD1 oligomerization has recently been 
proposed that applies to many SOD1 mutations of various natures distributed along the 
length of the protein where the apo-SOD1, before it is metallated, is susceptible to 
oligomerization (Banci et al., 2008). 
 
5.5 Cytoskeletal dysfunction 
The neuronal intermediate filament network is composed largely of neurofilaments and is 
responsible for maintaining cell shape and axonal caliber. Abnormal neurofilament 
accumulations are a pathological feature observed in spinal cord motoneurons of human ALS 
cases (Hirano et al., 1984, 1984b; Fig. 10 a, b) and mutant SOD1 transgenic mice (Gurney et 
al., 1994; Tu et al., 1996; Morrison et al., 1996; Zhang et al., 1997; Dal Canto & Gurney, 
1997; Fig. 10 c, d). Reduced expression of neurofilament-light (NF-L), causing changes in 
the stoichiometry of neurofilament subunits, has been reported in sporadic and familial ALS 
cases, SOD1G93A transgenic mice, and a cell culture model of ALS (Bergeron et al., 1994; 
Zhang et al., 1997; Wong et al., 2000; Menzies et al., 2002b; Fig. 10 e). Mutant, but not 
wild-type, SOD1 has been reported to bind directly to the 3′ untranslated region of NFL 
mRNA, leading to destabilization and increased degradation of mRNA (Ge et al., 2005). NF-
L is required for assembly of medium and heavy neurofilament subunits, so changes in its 
expression may disrupt neurofilament assembly and trigger aggregation. ROS produced by 
SOD1 have also been reported to attack NF-L subunits as the peroxidase activity of SOD1 
causes dityrosine cross-link formation and aggregation of NF-L subunits (Kim et al., 2004). 
SOD1-catalyzed peroxynitrite production selectively nitrates NF-L tyrosine residues in brain 
homogenates to inhibit the normal assembly of unmodified neurofilament subunits (Crow et 
al., 1997b). The zinc-binding affinity of NF-L is sufficient to potentially remove zinc from 
both wild-type and mutant SOD1, particularly those mutants with reduced zinc binding, 
thereby increasing the peroxynitrite-mediated tyrosine nitration activity catalyzed by SOD1 
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(Crow et al., 1997). In this way, ROS produced by mutant SOD1, and particularly mutants 
with reduced zinc binding, may lead to disruption of the neuronal cytoskeleton. 
                
Fig. 10. Neurofilament involvement in motoneuron disease. (a, b) Aberrant accumulation 
of neurofilaments is a common feature in motoneuron cell bodies and axonal swellings of 
sporadic ALS. (a) Silver staining reveals swirling masses of neurofilaments swelling a 
motoneuron cell body in the spinal cord of a sporadic ALS patient. (b) A spheroidal swelling 
comprising masses of tangled neurofilaments in a proximal axonal segment of a spinal 
motoneuron from a sporadic ALS patient. Note that the cell body of this neuron appears to be 
normal. (c, d) Disorganized neurofilaments in the cell body (c) and spheroidal axonal 
swellings (c, d) of a mouse that has developed motoneuron disease by expressing a point 
mutation (NF-LL394P) in the neurofilament light polypeptide (NF-L) gene. (e) Deletions or 
insertions identified in the KSP (lysine-serine-proline) repeat domain of the neurofilament 
heavy polypeptide (NF-H) gene from SALS and FALS patients (adapted from Cleveland & 
Rothstein, 2001).  
 
5.6 Involvement of non-neuronal cells  
The concept that non-neuronal cells could affect the viability of motoneurons stems from the 
observation that substantial activation of microglial and astroglial cells in ALS is one of 
earliest microscopic manifestations of this disease (Ince et al., 1996). Nonetheless, it has 
been difficult to obtain decisive data to test this hypothesis or to discern whether the 
activation of astrogliosis or microgliosis is detrimental or beneficial. Experiments with mice 
have shown that the specific expression of mutant SOD1 in motoneurons or glia fails to 
trigger motoneuron degeneration (Gong et al., 2000; Pramatarova et al., 2001). With the 
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caveat that the levels of expression of mutant SOD1 in the targeted cells might have been 
insufficient to induce a phenotype, these experiments favour the view that motoneuron death 
in transgenic ALS mice is not cell autonomous. Analyses of chimeric mice with mixed 
populations of cells expressing either endogenous or transgenic mutant SOD1 are consistent 
with this view (Clement et al., 2003). In these mice, motoneurons expressing transgenic 
G93A or G37R SOD1 fail to degenerate if they are adjacent to large numbers of supporting 
cells (such as astrocytes and glia) without the mutant protein. Reciprocally, motoneurons 
without the transgene demonstrate pathology if surrounded by non-neuronal cells with the 
mutant SOD1 transgene. The minimal sets of mutant-expressing cell types required for the 
development of motoneuron degeneration are still poorly defined. Recent studies with 
deletable transgenes have documented that expression of the mutant SOD1 transgene in 
microglia accelerates the late phase of murine ALS (Boillée et al., 2006). Parallel studies 
suggest that expression of the mutant SOD1 transgene within the macrophage lineage 
(presumably encompassing microglial cells) is not required for the ALS phenotype (Wang et 
al., 2005). ROS released from damaged motoneurons have been found to disrupt glutamate 
uptake into neighboring astrocytes, thereby leading to higher extracellular glutamate levels 
and increased excitotoxicity (Rao et al., 2003). ROS could also activate glial cells, resulting 
in release of further ROS, reactive nitrogen species, and proinflammatory cytokines that 
activate neighboring glial cells (Banati et al., 1993) and could be neurotoxic (Giulian, 1993; 
Koutsilieri et al., 2002; Zhao et al., 2004;). Glial involvement may therefore be one way in 
which motoneuron degeneration, which often starts focally, spreads to contiguous 
motoneuron populations (Brooks et al., 1995). 
 
5.7 Defects in RNA processing and trafficking 
Only recently RNA processing has become implicated in the pathogenesis of ALS, with the 
discovery of mutations in two genes with RNA / DNA-binding functions, TDP-43 (Kabashi 
et al., 2008; Sreedharan et al., 2008; Fig. 11 A) and FUS / TLS (Kwiatkowski et al., 2009; 
Vance et al., 2009; Fig. 11 B), being identified in FALS patients (Lagier-Tourenne & 
Cleveland, 2009). ALS-causing mutations in both genes result in the translocation of mutant 
proteins from the nucleus to the cytoplasm, where they form inclusions. Whether these 
cytoplasmic inclusions are toxic or act to sequester protein remains unclear. Whether 
oxidative stress contributes to this process is also unknown. However, oxidation of mRNA 
has been identified in ALS patients and in transgenic mice expressing a variety of FALS-
 31 
linked SOD1 mutations (Chang et al., 2008). In mutant SOD1G93A mice, increased mRNA 
oxidation is observed in spinal cord motoneurons and oligodendrocytes at presymptomatic 
ages. Some mRNA transcripts are more vulnerable to oxidation than others, with RNA 
species encoding proteins involved in mitochondrial electron transport and protein 
biosynthesis, folding, and degradation and SOD1 itself being more highly oxidized. Although 
treatment with the antioxidant vitamin E does not alter survival of SOD1G93A mice, it reduces 
mRNA oxidation, delays disease onset (defined by motor and pathological indications), and 
improves motor performance during the disease (Chang et al., 2008). 
 
Fig. 11. TDP-43 and FUS / TLS Mutations in ALS. (A) Thirty dominant mutations in 
TDP-43 have been identified in sporadic (red) and familial (black) ALS patients, with most 
lying in the C-terminal glycine-rich region of TDP-43. All are missense mutations, except for 
the truncating mutation TDP-43Y374X. (B) Fourteen mutations in FUS / TLS have been 
identified in familial ALS cases, with most lying in the final 13 amino acids of this protein 
(R514S and G515S are found in cis; adapted from Lagier-Tourenne & Cleveland, 2009). 
 
6. Persistent Na+ conductances in ALS 
6.1 Hyperexcitability and persistent Na+ conductances in ALS patients 
From a clinical perspective, cortical hyperexcitability, together with muscle cramps and 
fasciculations are inevitable features of both familial and sporadic forms of ALS (Roth, 1984; 
Miller & Layzer, 2005). Studies of axonal excitability undertaken in ALS patients establish 
that strength-duration time constant (τSD) is increased (Mogyoros et al., 1996). τSD is a 
measure of the rate at which the threshold current for a target potential declines as the 
stimulus duration increases (Bostock, 1983; Bostock & Rothwell, 1997). Computer 
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modelling of the behaviour of human motor axon suggests that τSD reflects persistent Na+ 
conductances which constitute approximately 1 % of total Na+ current in motor axons 
(Bostock & Rothwell, 1997). Specifically, increasing the fraction of the persistent Na+ 
current by means of membrane depolarization prolongs τSD. Over the last years, techniques 
have been developed to assess τSD in a clinical setting using a computerized threshold 
tacking protocol (Kiernan et al., 2000). Widespread abnormalities in axonal ion channel 
function, including reduction of slow and fast K+ channel conductances combined with 
upregulation of persistent Na+ conductances (Vucic & Kiernan, 2006; Tamura et al., 2006), 
have been reported in SALS and proposed as a likely mechanism underlying the generation 
of the ectopic activity of motor axons leading to cramps and fasciculations (Mogyoros et al., 
1996; Kiernan & Burke, 2004; Vucic & Kiernan, 2006). Whether such changes are intrinsic 
to the process of axonal degeneration, or develop as an epiphenomenon, remains to be 
clarified. In addition to underlying the generation of such ectopic axonal activity, 
abnormalities of axonal ion channel function, in particular upregulation of persistent Na+ 
conductances, has been associated with the process of axonal degeneration (Kanai et al., 
2003). Further, in SALS patients, cortical hyperexcitability is correlated with upregulation of 
persistent Na+ conductances (Vucic & Kiernan, 2006b), thereby suggesting a ‘dying forward’ 
process, which proposes that cortico-motoneurons drive death of anterior horn cells (Eisen et 
al., 1992). The notion of a dying forward process as a potential mechanism of 
neurodegeneration in ALS is further supported by finding that cortical hyperexcitability 
precedes the onset of FALS (Vucic et al., 2008). In addition, a recent report by Vucic and 
Kiernan (2010) has documented an increase in the τSD in FALS patients (Fig. 12). The 
upregulation of persistent Na+ conductances, expressed as τSD, correlates with peripheral 
markers of disease burden such as the decreased amplitude of the compound muscle action 
potential, and the Neurophysiological Index that also includes the frequency and latency of a 
series of electrical responses of skeletal muscle (de Carvalho & Swash, 2000). Furthermore, 
the τSD is also correlated with measures of cortical excitability, like the short interval 
intracortical inhibition (Vucic & Kiernan, 2010). In summary, the proposed increase in 
persistent Na+ conductances appears to be linked to the process of axonal degeneration and 
cortical hyperexcitability. 
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Fig. 12. Mean data illustrating that the strength-duration time constant (τSD) was 
significantly increased in both familial amyotrophic lateral sclerosis patients (FALS) and 
sporadic amyotrophic lateral sclerosis (SALS) patients when compared with asymptomatic 
superoxide dismutase-1 (SOD-1) gene mutation carriers and controls (*p<0.05; adapted from 
Vucic & Kiernan, 2010). 
 
6.2 Persistent Na+ conductances and electrophysiological properties in ALS 
animal models  
The findings concerning persistent Na+ conductances in human ALS patients are consistent 
with recent studies reporting upregulation of persistent Na+ current in the transgenic 
SOD1G93A mouse model (Kuo et al., 2005; van Zundert et al., 2008; Pieri et al., 2009). 
Specifically, using patch-clamp techniques, augmented persistent Na+ conductances are 
reported in presymptomatic cortical, brainstem and spinal motoneurons of the SOD1G93A 
model (Kuo et al., 2005; van Zundert et al., 2008; Pieri et al., 2009). Furthermore, these 
studies have examined the passive membrane properties and the pattern of motoneuron 
repetitive firing, demonstrating that, while the former are similar in control and G93A 
motoneurons, the firing frequency increases significantly in the G93A motoneurons, because 
of their higher persistent sodium current (Kuo et al., 2005; van Zundert et al., 2008; Pieri et 
al., 2009). Nonetheless, the electrophysiological phenotype is complex, as demonstrated by 
the work by Pambo-Pambo et al. (2009). This study compares the properties of control 
mouse motoneurons in the second postnatal week to those of two different SOD1 mutant 
lines, the SOD1G93A low expressor line and the SOD1G85R line. The authors show that very 
early changes in excitability occur in SOD1 mutant motoneurons. The SOD1G93A low 
expressor line displays specific differences not found in other mutant lines including a more 
depolarized membrane potential, larger spike width, and slower spike rise slope. After 
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injecting current pulses, SOD1G93A low expressor cells are hyperexcitable. Low expressor 
mutants show reduced total persistent inward currents compared with control motoneurons. 
The differences observed between these mutants could be due to the diverse toxic properties 
of the mutated SOD1 proteins (Prudencio et al., 2009) and / or to different timing of 
developmental processes interacting with compensation mechanisms. 
 
7. Hypoglossal nucleus 
The hypoglossal nucleus (XII cranial nucleus) is located in the medulla oblongata close to the 
midline immediately beneath the base of the fourth ventricle (Fig. 13). It innervates the 
tongue intrinsic and extrinsic muscles. The extrinsic muscles have bone attachment, and 
include hypoglossus, styloglossus, geniohyloid and genioglossus muscles, whose activity 
control protrusion, retraction and elevation of the tongue. Intrinsic muscles are not attached 
to the bone and are located within the body of the tongue. They are composed of vertical, 
transversal, superior and inferior longitudinal muscles that alter the shape of the tongue. In 
the rat, the ventrolateral subdivision of XII nucleus innervates the tongue protractor muscles, 
while the dorsal part innervates retractor muscles, and the motoneurons of the middle third of 
the XII nucleus innervate tongue intrinsic muscle (Aldes, 1995; McClung & Goldberg, 1999, 
2000; Sokoloff, 2000). Such XII nucleus organization allows the fine control of various 
tongue movements, including mastication, sucking, swallowing, controlling respiration and 
others oral behaviours (Lowe, 1980). 
At least 90 % of neurons within the hypoglossal nucleus are motoneurons, while the 
remaining ones are interneurons (Viana et al., 1990). Hypoglossal motoneurons (HMs) are 
large (25-50 µm), multipolar cells, whereas interneurons are smaller (10-20 µm), round to 
oval shaped neurons. Motoneurons spread their dendrites extensively within the XII nucleus 
and the neighboring reticular formation, while the interneurons have few dendritic processes 
and are located at the ventrolateral or dorsolateral borders of the nucleus. Axons of the HMs 
exit the hypoglossal nucleus, penetrate the dura mater and coalesces to form the hypoglossal 
nerve (XII cranial nerve) in the hypoglossal canal (Fig. 13). The XII nerve then runs to the 
floor of the mouth, where its fibers are distributed to intrinsic and extrinsic muscles of the 
tongue.   
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Fig. 13. Ventral view of human brainstem. The brainstem is composed of three major 
divisions: medulla, pons, and midbrain. The hypoglossal nerve (XII cranial nerve) originates 
in the medulla (adapted from Kandel et al., 1991). 
 
The XII nucleus receives innervation from the reticular formation, other brainstem centers 
and higher centers of the brain (Borke et al., 1983; Dobbins & Feldman, 1995). The primary 
source of the inputs to the XII nucleus arises from the caudal reticular formation immediately 
ventral to the nucleus of the solitary tract (NTS), which is termed dorsal medullary reticular 
column (DMRC; Cunningham & Sawchenko, 2000; Fig. 14). Projections from the DMRC 
are largely bilateral, distributed to both dorsal and ventral subdivisions of XII nucleus, and, 
therefore, can simultaneously innervate both tongue protractor and retractor muscles. This 
arrangment shows an independent, albeit coordinated activation of antagonist muscles of the 
tongue (Dobbins & Feldman, 1995; Fay & Norgren, 1997; Cunningham & Sawchenko, 
2000). Human XII nucleus receives cortico-nuclear fibers from the pre-central gyrus of both 
cerebral hemispheres; however, no direct cortical connections to orofacial motor nuclei, 
including the XII nucleus, have been shown in rats (Travers & Norgren, 1983). Thus, 
voluntary motor commands in rat must pass through various relay stations.  
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Fig. 14. Schematic representation of XII nucleus innervation. Anterograde labeling shows 
that hypoglossal nuclei (XII) receive inputs from dorsomedial reticular column (DMRC), 
where labeling dye was injected. DMRC innervates both contralateral and ipsilateral XII 
nuclei. Abbreviations: NTS, nucleus tractus solitarius; DMX, dorsal motor nucleus of the 
vagus nerve; Gr, gracile nucleus; EC, external cuneate nucleus; stv, spinal tract of the 
trigeminal nucleus; SNV, spinal trigeminal nucleus; LRN, lateral reticular nucleus; py, 
pyramidal tract; IO, inferior olive (modified from Cunningham & Sawchenko, 2000). 
 
Excitatory premotoneurons in the XII nucleus are glutamatergic, while the inhibitory ones 
are GABAergic and glycinergic (Rekling et al., 2000). In vitro recordings from neonatal rats 
show that HMs express both NMDA and non-NMDA receptors at synaptic sites (O'Brien et 
al., 1997). However, in vivo recording from adult rats (Ouardouz & Durand, 1994) and 
recordings from HM embryonic organotypic cultures (Launey et al., 1999) suggest that 
NMDA receptors are not directly involved in synaptic transmission, and could be located 
either extrasynaptically or at silent synapses. The neurotransmitters GABA and glycine 
operate by activating Cl- channels. GABA receptors mainly belong to GABAA class and are 
reversibly blocked by bicuculline, while glycine receptors are blocked by strychnine 
(Barnard et al., 1993; Kuhse et al., 1995; Donato & Nistri, 2000). On brainstem 
motoneurons, GABAA and glycine receptors are present on the same neuron, and HMs 
receive both GABAergic and glycinergic synaptic inputs (O'Brien & Berger, 1999). On 
hypoglossal motoneurons, however, glycinergic events are significantly faster and larger in 
amplitude than GABAergic currents, and occur at higher frequency (Donato & Nistri, 2000). 
 
7.1 Hypoglossal nucleus: a model for studying oxidative stress in relation to ALS  
Hypoglossal motoneurons are among the most strongly damaged neurons in ALS (Krieger et 
al., 1994; Lips & Keller, 1999). It has been suggested that HM vulnerability could be due to 
their characteristic intracellular Ca2+ homeostasis (Ladewig et al., 2003), expression of Ca2+ 
permeable AMPA channels (Del Cano et al., 1999), or impaired glutamate uptake 
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(Sharifullina & Nistri, 2006). HM dysfunction, resulting in dysarthria and dysphagia, is often 
a very early symptom of ALS (Medina et al., 1996; Shaw & Ince, 1997), and initial bulbar 
symptoms are diagnosed on the basis of the patient’s ability to speak and manage food and 
drinks (Kühnlein et al., 2008).  
Current theories of ALS propose that motoneuron damage may result from oxidative stress as 
indicated by the host (>140) of SOD-1 mutations implicated in the genetic forms of the 
disease that, however, are only 10 % of all clinical cases and have generated a large number 
of mouse genetic models (Vucic & Kiernan, 2009). Since the vast majority of ALS cases are 
sporadic, presumably implying an environmental toxic agent (Cleveland & Rothstein, 2001), 
and oxidative stress has also been implicated as a major player, even in the absence of 
mutated SOD1 (Shaw et al., 1995; Ferrante et al., 1997; Bogdanov et al., 2000; Ihara et al., 
2005), wildtype HMs are an appropriate model for studying the consequences of a free-
radical challenge.  
The present study used HMs from the neonatal rat brainstem to investigate how hydrogen 
peroxide and nitric oxide could affect synaptic transmission and intrinsic motoneuron 
excitability in relation to survival. We wished to find out if even a transient oxidative stress 
might be sufficient to trigger off electrophysiological alterations accompanied by expression 
of the ATF-3 transcription factor typical of motoneuron distress (Tsujino et al., 2000; Hai & 
Hartman, 2001; Vlug et al., 2005) and the S100B protoplasmic astrocytic marker, known to 
be associated with brain damage and degenerative brain disease (Migheli et al., 1999; 
Rothermundt et al.; 2003; Blackburn et al., 2009). Both ATF-3 and S100B have a Janus-like 
function: the former subserves either damage repair or degeneration depending on the nature 
of the insult (Tsujino et al., 2000; Nakagomi et al., 2003; Vlug et al., 2005); the latter can 
exert beneficial (neurotrophic) or detrimental (neurotoxic) effects on surrounding glia and 
neurons depending on its concentration (Rothermundt et al., 2003).  
The hypoglossal nucleus have been extensively studied to clarify the basic pathogenethic 
mechanisms of ALS and to understand its selective vulnerability. Funk’s laboratory has 
characterized the differential expression of calcium binding proteins, of Group I 
metabotropic glutamate receptors, of GluR2 AMPA Receptor Subunit, and of voltage-
activated Ca2+ channels in motoneurons at low and high risk for degeneration in ALS (Laslo 
et al., 2000, 2001, 2001b; Miles et al., 2004), indicating how the nucleus hypoglossus is at 
very high risk of neurodegeneration. SOD1G93A neonatal and adult hypoglossal motoneurons 
have also been studied to elucidate Ca2+ homeostasis (von Lewinski et al., 2008; Jaiswal & 
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Keller, 2009). These authors have reported low Ca2+ buffering capabilities in such vulnerable 
motoneurons, and considered it a significant risk factor for degeneration (von Lewinski et al., 
2008; Jaiswal & Keller, 2009). Changes in HM activity of neonatal brainstem slice 
preparations have been investigated using as a source of tissue both wild-type and SOD1G93A 
mice, demonstrating higher excitability of the mutant neurons even at presymptomatic stage 
(van Zundert et al., 2008). 
 
8. Hydrogen peroxide 
Hydrogen peroxide is a reactive oxygen species and is generated as a by-product of aerobic 
metabolism in cells, due to molecular oxygen partial reduction. ROS, together with RNS, are 
disruptive to cells redox state if not detoxified. Indeed, over-production and/or under-
detoxification of ROS / RNS, or even normal demands for these reactive species may cause 
oxidative / nitrosative stress. Among all organs in the body, the brain is particularly prone to 
oxidative stress-induced damage because of the high oxygen demand of this organ, the 
abundance of redox-active metals (iron and copper), the high levels of oxidizable 
polyunsaturated fatty acids, and the fact that neurons are post-mitotic cells with relatively 
restricted replenishment by progenitor cells during the lifespan of an organism. ROS / RNS-
induced oxidative stress to the brain has been implicated in normal aging and in various 
neurodegenerative disorders, including ALS, Parkinson’s disease, Alzheimer’s disease, and 
ischemia-reperfusion injury (Beckman et al., 1990; Ames & Shigenaga, 1992; Dreher & 
Junod, 1995; Golino et al., 1996; Lewen et al., 2000; Chandra et al., 2000). 
Over millions of years of evolution, cells have developed a multitude of anti-oxidant 
mechanisms to cope with the potential damaging effects of ROS and RNS. These 
mechanisms include anti-oxidant enzymes (such as superoxide dismutase, catalase, 
glutathione peroxidase, and the thioredoxins), as well as non-protein antioxidants (such as 
glutathione, GSH; α-tocopherol, vitamin E; ascorbic acid, vitamin C; bilirubin, and 
coenzyme Q10). Glutathione is a major non-protein antioxidant in cells and the ratio of its 
reduced and oxidized form (GSH / GSSG) is an indicator of cellular redox status (Schafer & 
Buettner, 2001; Jones, 2002). The combination of anti-oxidant proteins and smaller 
molecules offers a versatile and flexible system to control intracellular levels of ROS / RNS. 
The high efficiency of this system in cells, including neurons, is maintained through the 
diverse subcellular localization of the antioxidants, their biochemical properties, and the 
differential inducibility of anti-oxidant enzymes at both transcriptional and translational 
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levels. Although cellular antioxidants are highly efficient in maintaining redox homeostasis, 
such anti-oxidant defenses do not completely eradicate ROS / RNS from the intracellular 
environment. Nor would such eradication be desirable as ROS / RNS are essential 
components of a repertoire of signals on which neurons depend to respond to internal and 
external, environmental and developmental cues (Gutierrez et al., 2006). Numerous 
neurotransmitter systems are sensitive to ROS, including adrenergic (Kvaltinova et al., 
1993), dopaminergic (Joseph et al., 1998), serotonergic (Muakkassah-Kelly et al., 1982) and 
GABAergic (Schwartz, 1988; Sah & Schwartz-Bloom, 1999) systems. The effects of ROS on 
neurotransmission can occur via various mechanisms (van der Want et al., 1992). For 
example, ROS may interact with neurotransmitter receptors and ion transport proteins such 
as channels, pumps, and transporters, leading to changes in receptor activity and ionic 
homeostasis. In addition, ROS can alter ligand-receptor interactions or ion transport 
indirectly via actions within the lipid environment of cell membranes. Among the most 
important signaling pathways modulated by H2O2 are those involving kinase and phosphatase 
enzymes (Denu & Tanner, 1998; Nakamura et al., 1993; Klann et al., 1998; Whisler et al., 
1995). For GABAergic neurotransmission, ROS have been shown to increase release (and 
decrease uptake) of GABA in a variety of neuronal preparations (Rego et al., 1996; 
Saransaari & Oja, 1998; Sah & Schwartz-Bloom, 1999). A recent study indicated that H2O2 
increased GABAergic mIPSCs through presynaptic inositol-1,4,5-trisphosphate receptor 
(IP3R)-sensitive Ca2+ release mechanism (Takahashi et al., 2007). Furthermore, ROS / RNS 
signals can influence synaptic plasticity (Kamsler & Segal, 2004, 2007; Serrano & Klann, 
2004; Kishida & Klann, 2007). This pathway contains redox-sensitive proteins that can 
undergo reversible oxidation / reduction and thus modulate their function based on the 
cellular redox status (Kohr et al., 1994; Suzuki et al., 1997; Forman et al., 2002; Lipton et 
al., 2002; Hidalgo, 2005; Janssen-Heininger et al., 2008). This modulation can be conferred 
by ROS / RNS either directly or indirectly through other redox-sensitive molecules such as 
glutathione or thioredoxins. Many of these proteins contain redox-sensitive cysteine residues 
that may be oxidized to either sulfenic acid or disulfide bonds, thus producing changes in 
structural and functional states of the respective proteins (Denu & Tanner, 1998; Droge, 
2003; Piotukh et al., 2007). The downstream effects are, for example, the activation / 
deactivation of a variety of effectors, such as kinases, phosphatases and transcription factors 
(e.g., Nrf2 and NF-κB; Arrigo, 1999). 
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9. Nitric oxide 
Nitric oxide (NO) is a crucial signaling molecule in cardiovascular (Ignarro et al., 1987; 
Palmer et al., 1987), reproductive (Hurt et al., 2006), immune (Bogdan, 2001), and central 
nervous systems (CNS; Bredt et al., 1990; Bon & Garthwaite, 2003; Garthwaite, 2008). NO 
exhibits properties ideally suited for a transcellular messenger: being highly soluble and 
mobile (unimpeded by cell membranes), widely synthesized and of limited lifetime. It acts 
via a well-characterized NO-cGMP pathway (Southam & Garthwaite, 1993), although S-
nitrosylation of proteins, generation of ROS, and regulation of cellular respiration also 
contribute to physiological and pathological roles (Ahern et al., 2002).  
In mammals, NO is synthesized by nitric oxide synthases (NOS) through the conversion of 
L-arginine to NO and L-citrulline. NOS are complex proteins found constitutively in two 
isoforms, neuronal (nNOS) and endothelial (eNOS). The third, inducible, type (iNOS) is 
rarely present normally but can be expressed in numerous cell types (prototypically in 
macrophages, mainly in microglia of the CNS) when subjected to immunological challenge. 
NOS have distinct functional and structural features (reviewed by Alderton et al., 2001; 
Stuehr et al., 2004). nNOS is activated by Ca2+ complexed with calmodulin and has a wide 
but uneven distribution in the mammalian brain (Bredt et al., 1991; Vincent & Kimura, 
1992). Although nNOS is the most abundant isoform generally found in the central and 
peripheral nervous systems, it is widely expressed in the neocortex, cerebellum, and 
hippocampus, and is closely associated with NMDA receptors (Brenman et al., 1996) and 
synaptic plasticity (Hopper & Garthwaite, 2006; Jacoby et al., 2001; Son et al., 1996). 
NO mediates its effect by activating guanylate cyclases (GC) for the production of cGMP, a 
well-known second messenger (Reynolds & Burstyn, 2000). GC is an αβ-heterodimer of 
which there are two known isoforms, α1β1 and α2β1 (Denninger & Marletta, 1999; 
Koesling et al., 2004). Although widespread, the two NO effector isoforms have a diverse 
cellular distribution in the brain (Budworth et al., 1999; Gibb & Garthwaite, 2001; Mergia et 
al., 2003; Szabadits et al., 2007) and, at the subcellular level, may also have different 
locations because the α2β1 effector is enriched in synapses (Russwurm et al., 2001), while 
the other isoform, α1β1, may be cytosolic in part, but there is evidence that it may become 
plasma membrane-associated under conditions of raised intracellular Ca2+ (Zabel et al., 2002) 
or exposure to cannabinoids (Jones et al., 2008). NO also reacts with cysteine residues on 
target proteins to form nitrosothiols that mediate signal transduction. S-nitrosylation is a 
reversible process facilitated by an acid-base amino acid motif within the protein structure 
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(Stamler et al., 1997; Stamler et al., 2001). However, deregulation of S-nitrosylation due to 
increased nitrosative stress can contribute to the pathogenesis of various neurodegenerative 
diseases like ALS. Schonhoff et al. (2006) have demonstrated that selective depletion of 
nitrosothiols is prominent in the spinal cord of G93A and G85R mutant SOD1 transgenic 
mice. The mechanism of how the depletion of nitrosothiols can contribute to motoneurons 
degeneration in ALS is not known, but this report suggests it to be related to decreased levels 
of S-nitrosylated glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Since S-
nitrosylation of GAPDH is known to regulate its translocation to the nucleus, a process 
critical for cell survival, it is hypothesized that decreased S-nitrosylation of GAPDH can 
contribute to the demise of motoneurons in ALS.  
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Aims of the study 
The present study aimed at addressing the following scientific questions: 
 What is the effect of oxidative stress, for example induced by H2O2, on excitatory & 
inhibitory synaptic transmission and excitability of HMs? 
 What is the nucleus hypoglossus response to H2O2 in terms of intracellular generation of 
reactive oxygen species, cell survival & neuronal / astroglial distress? 
 What are the electrophysiological changes induced by sodium nitroprusside (NaNP), a 
NO donor, on HMs and how does this effect compares with those evoked by H2O2? 
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Materials & Methods 
1. Slice preparation 
All experiments were carried out in accordance with the regulations of the Italian Animal 
Welfare act (DL 27 ⁄ 1 ⁄ 92 n.116) following the European Community directives no. 86 ⁄ 609 
93 ⁄ 88 (Italian Ministry of Health authorization for the local animal care facility in Trieste D 
69 ⁄ 98-B), and approved by the local authority veterinary service. As full details of the 
experimental methods have been published earlier (Quitadamo et al., 2005; Lamanauskas & 
Nistri, 2006, 2008), only a brief account is provided hereafter. Brainstem slices (250 µm 
thick) from neonatal (P1-P5 day old) urethane - anaesthetized Wistar rats were cut in ice-
cold, oxygenated (95% O2 ⁄ 5% CO2) Krebs solution, containing (in mM): NaCl, 130; KCl, 3; 
NaH2PO4, 1.5; CaCl2, 1; MgCl2, 5; NaHCO3, 25; glucose, 100 (pH 7.4; 300-320 mOsm). 
After 40 min recovery at 32 ºC and 1 h at room temperature, they were used for recording. 
 
2. Electrophysiological recordings 
HMs were identified within the nucleus hypoglossus with an infrared video-camera (Fig. 15 
A, B). All cell recordings were obtained, at ambient temperature, under whole-cell patch-
clamp conditions. For voltage clamp experiments, patch electrodes had 3-4 MΩ resistance, 
whereas for current clamp experiments they had 8-10 MΩ resistance. Cells were clamped at 
values between -60 and -70 mV holding potential (Vh), as close as possible to initial resting 
potential. Cells were used for analysis when series resistance increases did not exceed 10%. 
Voltage-activated currents were measured in response to slow (either 21 mV ⁄ s or 42 mV ⁄ s) 
triangular voltage-clamp commands from -80 mV to +20 mV and back (Lamanauskaus & 
Nistri, 2008) in accordance with the studies by Schwindt & Crill (1980). In current clamp 
mode, neurons were kept at their initial resting level of membrane potential (Vm) while the 
bridge was routinely balanced throughout the experiment. Intracellular DC currents (200-500 
pA; 500 ms) were injected into HMs to study firing properties and afterhyperpolarization 
(AHP) amplitude. Voltage and current pulse generation and data acquisition were performed 
using pClamp 10.0 software (Axon Instruments, Molecular Devices, Sunnyvale, CA, USA). 
Patch pipettes were filled with intracellular solution containing (in mM): CsCl, 130; NaCl, 5; 
MgCl2, 2; CaCl2, 1; HEPES, 10; EGTA, 10; ATP-Mg, 2; sucrose, 2 (pH 7.2 with CsOH; 280-
300 mOsm) for voltage clamp experiments. Intracellular CsCl, that minimized the leak 
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current of the recorded cell, was used to enable larger changes in Vh. For current clamp 
experiments, 130 mM KCl always replaced CsCl. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   
               
Fig. 15. HM identification within the brainstem slice. (A) Schematic representation of a 
brainstem slice. Recordings were done via patch pipette. The following structures can be 
identified: AP, area postrema; Cu, cuneate nucleus; EC, external cuneate nucleus; Gr, gracile 
nucleus; IO, inferior olive; LRN, lateral reticular nucleus; mlf, medial longitudinal 
fasciculus; mrf, medullary reticular formation; NTS, nucleus of the tractus solitarius; SNV, 
spinal trigeminal nucleus; py, pyramidal tract; X, vagal nucleus; XII, hypoglossal nucleus. 
(B) Confocal image of a hypoglossal nucleus labeled with the motoneuron marker SMI 32 
(Jacob et al., 2005; Raoul et al., 2005; green pseudocolour) and Hoechst 33342 DNA 
staining (blue pseudocolour). Single motoneurons could be easily identified within the XII 
nucleus.  
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3. Solutions and drugs 
Slices were superfused (2-3 mL ⁄ min) with a gassed solution containing (in mM): NaCl, 130; 
KCl, 3; NaH2PO4, 1.5; CaCl2, 1.5; MgCl2, 1; NaHCO3, 25; glucose, 10 (pH 7.4; 300–320 
mOsm). The following drugs were used: 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), D-
amino-phosphonovalerate (APV), bicuculline methiodide (bicuculline) and strychnine 
hydrochloride (strychnine) purchased from Tocris (Bristol, UK); MgCl2, H2O2 and sodium 
nitroprusside dehydrate (NaNP) were from Sigma (Milan, Italy). Tetrodotoxin (TTX) was 
obtained from Latoxan (Valence, France), thapsigargin from Calbiochem (Merck Chemicals, 
Darmstadt, Germany). Drugs were applied by superfusion. Since the focus of the present 
study was on the toxic activity of free oxygen radicals, as a routine, H2O2 was applied at 1 
mM concentration because this dose was previously shown to produce neurotoxicity of in 
vitro spinal neurons (Taccola et al., 2008). Similar effects were seen in preliminary 
experiments with 0.5 mM H2O2. We checked that 1 mM H2O2 did not vary the pH of the 
superfusing solution (observed pH change switching from control Krebs to H2O2 containing 
solution was from 7.38 to 7.40). 
To investigate nitrosative stress effects on HMs, we perfused brainstem slices with 500 µM 
NaNP, a NO donor. Indeed, near-micromolar NO concentrations are associated with toxicity 
and cell death (Dawson et al., 1993; Liu & Martin, 2001; Hall et al., 2009), and, in the case 
of NaNP, Southam and Garthwaite (1991) estimate that a range from 1 µM to 10 mM in the 
perfusate corresponds to a concentration near the tissue ranging from 0.1 nM to 1 µM. 
Accordingly, the dose of 500 µM used in the present work should correspond to a 
concentration in the recording chamber of 0.05 µM. 
 
4. Data analysis 
In voltage clamp experiments, cell input resistance (Rin) was calculated by measuring the 
current response to 10 mV hyperpolarizing steps from Vh. In current clamp experiments, Rin 
was calculated by measuring the voltage response to -50 pA current injections (Pagnotta et 
al., 2005; Quitadamo et al., 2005). Spontaneous and miniature, excitatory and inhibitory, 
postsynaptic currents (sPSCs, mIPSCs and mEPSCs) were detected using the template search 
software Clampfit 10.0 (Axon Instruments). Cumulative probability plots of synaptic events 
were constructed with SigmaPlot 9.01 software (Jandel Scientific, San Rafael, CA, USA). 
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Decay-time was calculated by exponential fitting of the decay phase of captured single 
events. In accordance with the standard protocols used by Ptak et al. (2005), Enomoto et al. 
(2006), Aracri et al. (2006) and Magistretti et al. (2006), persistent inward currents (PICs) 
were evoked by injecting triangular voltage commands at the rate of either 21 mV ⁄ s or 42 
mV ⁄ s. The voltage-activated inward current was obtained after subtracting the passive leak 
current (Cramer et al., 2007; Theiss et al., 2007), extrapolated from linear regression fits to 
the I-V curve at membrane voltages between -80 and -60 mV. The inward current area was 
also measured as the area below the trace baseline after leak correction. SigmaPlot 9.01 
software was used for linear regression analysis including the quantification of the time 
dependence of firing frequency. Gradual changes in spike firing following a long current 
pulse injection were investigated by Sawczuk et al. (1995) who used HMs of rat brainstem 
slices in control solution to show multiphasic decay in the firing frequency after the initial 
high rate. In analogy with these studies we examined changes in spike firing rate before and 
after application of H2O2 by fitting a cubic polynomial function to the plot of the interspike 
intervals versus the spike sequence in the train (see Fig. 22 D) as shown by the following 
equations: 
Control: y1 = 0.0148 + 0.0189x – 0.0029x2 + 0.0001x3 with r = 0.8528, and 
H2O2: y2 = 0.0084 + 0.0035x – 0.0002x2 + 3.92*10-6x3  with r = 0.8999.  
We then calculated the difference integral for the first 13 spikes in the plot and normalized 
the result with respect to control to give the % change. It is noteworthy that this analysis was 
performed with data obtained under non steady-state conditions because of the developing 
toxic action of H2O2 on HMs. Because H2O2 application was transient to mimic a temporary 
oxidative stress and it induced ongoing changes in baseline membrane potential and neuronal 
properties under non steady-state conditions, it was not feasible to perform standard tests of 
HM firing responses to varying amplitudes of injected current. CorelDraw (Vector Capital, 
San Francisco, CA, USA) was used for graphical data presentation. 
 
5. Intracellular measurement of reactive oxygen species (ROS) generation 
Generation of intracellular free oxygen radicals was evaluated with dihydrorhodamine 123 
(DHR 123; Molecular Probes, Invitrogen, Milan, Italy; Sánchez-Carbente	  et al., 2005; Jiang 
et al., 2006). At room temperature, continuously oxygenated, thin slices (250 µm thick) were 
first incubated in Krebs solution or 1 mM H2O2 for 30 min, then treated with 5 µΜ DHR 123 
and the cell-permeable DNA dye Hoechst 33342 (10 mg ⁄ ml stock from Molecular Probes, 
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Invitrogen; final dilution was 1:1000) in Krebs solution for 20 min. Slices were finally 
washed, transferred to a glass chamber containing Krebs solution (without fixation) and 
examined with a TCS SP2 Leica confocal microscope (×40). Hoechst 33342, used to 
counterstained slices, is a cell-permeable dye that, once bound to dsDNA, emits blue 
fluorescence. For fluorescence imaging of rhodamine 123 (Rho 123, the oxidized form of 
DHR 123), slices were visualized by excitation at 514 nm and emission at 530-610 nm. For 
each slice side and for both hypoglossal nuclei, a 40 µm z-stack (corresponding to one HMs 
plane) was acquired (5 µm step size); ImageJ software (version 1.43 j, Wayne Rasband, 
National Institutes of Health, USA) was used to create a 3D reconstruction of every 
hypoglossal nucleus in order to detect Hoechst 33342 and Rho 123 signal positive voxels. To 
avoid background noise, an automatic threshold was set for both Rho 123 signal and Hoechst 
33342 signal. Data are expressed as ratio of Rho 123 signal positive voxels versus Hoechst 
33342 signal positive voxels. 	  
 
6. Viability assay 
At room temperature, continuously oxygenated, thin slices (250 µm thick) were first 
incubated in Krebs solution or 1 mM H2O2 for 30 min or 1 h, then treated with propidium 
iodide (PI; 1 mg ⁄ ml stock from Sigma, Milan, Italy; final dilution was 1:3000) and Hoechst 
33342 (10 mg ⁄ ml stock; final dilution was 1:1000) in Krebs solution for 45 min. Slices were 
finally washed, transferred to a glass chamber containing Krebs solution (without fixation) 
and examined with a TCS SP2 Leica confocal microscope (×40). Hoechst 33342 provided 
the global number of cells (surviving plus damaged) in each tissue section. PI was used to 
investigate the number of cells killed by H2O2 treatment since it is a cell-impermeable DNA 
dye which can bind DNA and emits red fluorescence when cell and nuclear membranes have 
been damaged (Jones & Senft, 1985).	  For each slice side and for both hypoglossal nuclei, a 
40 µm z-stack was acquired (5 µm step size); Leica confocal software was used to create a 
2D average projection of each images series along z axis. An in house-written ImageJ 
software macro was used to count PI and Hoechst positive cells. Images were first converted 
into binary images with the nuclei coloured in black over a white background. Thereafter, 
only nuclei of specified size and circularity were analyzed and measurements relative to 
particles count were displayed. Data are expressed as ratio of PI positive cells versus Hoechst 
positive cells. 	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7. Immunohistochemistry  
Brainstems removed from P3-P5 rats were cut in two thick (500 µm) slices comprising the 
nucleus hypoglossus in ice-cold, oxygenated Krebs solution; slices were incubated (under 
continuous oxygenation) either in Krebs solution or in 1 mM H2O2 for 30 min at room 
temperature, and rinsed. Treated and untreated slices were always processed in parallel to 
minimize bias. Slices were fixed either immediately for SMI 32 and S100 at the end of H2O2 
application, or rinsed and kept for 1 h in Krebs solution for ATF-3 staining. To investigate 
the hypoglossal nucleus expression of neuronal nitric oxide synthase (nNOS) and guanylate 
cyclase (GC), brainstems removed from P3-P5 rats were immediately fixed. The fixative 
medium was phosphate-buffered saline (PBS) containing 4% paraformaldehyde (24 h at 4°C) 
followed by 30% sucrose PBS for cryoprotection (24 h at 4°C). Cryostat tissue sections (30 
µm) were collected sequentially and treated with blocking solution (1% fetal calf serum, 5% 
bovine serum albumin, 0.3% Triton X-100 in PBS) for 1 h at room temperature. Slices were 
then incubated overnight at 4°C with primary antibodies against SMI 32 (mouse monoclonal, 
1:200 dilution, Covance Research Products Inc., Berkeley, CA, USA), ATF-3 (rabbit 
polyclonal, 1:500 dilution, Santa Cruz Biotechnology, Santa Cruz, CA, USA), S100 (rabbit 
polyclonal, 1:100 dilution; Dako, Glostrup, Denmark), nNOS (rabbit polyclonal, 1 µg ⁄ ml 
diluition; Invitrogen, Camarillo, CA, USA), GC β1 subunit antibody (rabbit polyclonal, 
1:100 dilution; Abcam, Cambridge, UK). β1 subunit is common to the two known GC 
isoforms, namely α1β1 and α2β1 (Denninger & Marletta, 1999; Koesling et al., 2004). 
AlexaFluor 488 and 594 were used as secondary antibodies (1:500 dilution; Molecular 
Probes, Invitrogen, Milan, Italy) for 2 h at room temperature. Omission of the primary 
antibodies did not produce any signal. The use and specificity of SMI 32 and S100 antibodies 
are detailed in a recent report from our lab (Kuzhandaivel et al., 2010). The use of SMI 32 to 
stain rat motoneurons has been recently validated (Taccola et al., 2008; Mazzone et al., 
2010). Anti-S100 targets the S100B calcium binding protein found in the cytoplasm and 
nuclei of astrocytes and ependymal cells (Cocchia, 1981; Donato, 2003). In the adult rat 
brain, both fibrous and protoplasmic astrocytes express S100B (Cocchia, 1981; Didier et al., 
1986), but only the former express high amount of glial fibrillary acidic protein (GFAP), an 
intermediate filament protein characteristic for white matter astrocytes (Eng, 1985; Didier et 
al., 1986). According to Miller & Raff (1984), fibrous and protoplasmic astrocytes represent 
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distint classes of glial cells: the former are located primarily in the white matter, while the 
latter are found mainly in the gray matter and appear at least one week before fibrous 
astrocytes. In accordance with this notion, in the P4 rat nucleus hypoglossus, we could 
observe only very few GFAP (tested with mouse monoclonal anti-GFAP; 1:400; Sigma, 
Milan, Italy) positive astrocytes in the gray matter (Fig. 16 A) against a strong, diffuse 
labeling of S100B positive astrocytes (see Results, Fig. 26). To confirm that this observation 
was a typical characteristic of motor nuclei, we also investigated the presence of GFAP and 
S100B positive cells in the ventral horn area of the P4 rat spinal cord (Fig. 16 B, C), 
demonstrating a distribution of such cells analogous to the one in the nucleus hypoglossus. 
On the basis of the aforementioned considerations, in this report we considered S100B 
positive cells as protoplasmic astrocytes.  
          
Fig. 16. Astrocyte population in the P4 rat nucleus hypoglossus and spinal cord. (A) 
Example of a confocal image (20x) of hypoglossal nuclei labeled with GFAP (fibrous 
astrocyte marker; green pseudocolor) and Hoechst 33342 (blue pseudocolour). The inset 
(higher magnification) shows how GFAP labeling is limited to the central canal profile. (B) 
Example of GFAP (green pseudocolor) and S100B (protoplasmic astrocytic marker; red 
pseudocolor) immunoreactivity of the spinal cord ventral horn (fluorescence microscopy 
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image, 10x). (C) Histological example of GFAP (green pseudocolor) and DAPI (blue 
pseudocolor) staining of cells in the rat spinal cord (fluorescence microscopy image, 5x). 
After the incubation with the secondary antibody, slices were rinsed and stained with 
Hoechst 33342. Slices were mounted with Vectashield (Vector Laboratories Burlingame, 
CA, USA) to avoid photobleaching, and visualized with the confocal microscope (×10; ×20; 
×40). For quantifying S100B immunoreactivity, sections were analyzed with ImageJ 
software. Only astrocytes that showed S-100B staining co-localizing with Hoechst 33342 
were counted. CellCounter software (Glance Vision Technologies s.r.l., Trieste, Italy) was 
used to count SMI 32 immunopositive HMs. CellCounter is a tool for automatic 
classification and counting of cells; the parameters like cell diameter and signal intensity 
threshold can be automatically estimated in the sample. Concerning SMI 32 stained images, 
average parameters setting was: cell diameter, 19.07 µm; intensity threshold, 0.371. The 
number of SMI 32 positive neurons was similar in untreated and treated brainstem slices (see 
results). Because the confocal settings used for image acquisition were the same for treated 
and untreated slices, the average SMI 32 staining intensity was assumed to be identical for 
treated and untreated slices. Co-staining of ATF-3 and SMI 32 was analyzed on the basis of 
their covariance. In probability theory and statistics, covariance is a measure of how much 
two variables change together. Covariance can assume any value between -∞ and +∞. If 
covariance is positive, the two variables change concordantly; if covariance is negative, the 
two variables change in an opposite way; finally, two variables whose covariance is zero are 
called uncorrelated. In our samples, for each images pair of ATF-3 and SMI 32 staining, a 
function converted red green blue images (I) to graded gray levels (Ig). Thereafter, the 
average intensity value of every image was subtracted from each pixel intensity (“Ig - average 
Ig”). The covariance (C) value was the scalar product of the two images (“I1g - average I1g” 
for ATF-3 and “I2g - average I2g” for SMI 32) divided by the image pixel number according 
to the equation:  
C = <(I1g - average I1g), (I2g - average I2g)> / image pixel number 
When the covariance value was significantly higher than control, this indicated stronger 
ATF-3 staining intensity because the SMI 32 fluorescence remained similar.  
Covariance between ATF-3 staining and SMI 32 staining was analyzed by means of a 
MATLAB 7.1 software macro kindly provided by Dr. Walter Vanzella (Glance Vision 
Technologies). 
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8. Statistics 
Results were expressed as means ± SEM; n refers to the number of cells or animals, as 
indicated. For statistical calculations, we used SigmaStat 3.11 (Systat Software, Chicago, IL, 
USA): in particular, data distribution was first processed with a normality test and, then, with 
the Student’s t-test (power of performed test with alpha = 0.050) or the Mann-Whitney test 
used for parametric or for non-parametric data (for the latter, T represents the Mann-Whitney 
T statistic value, which is the sum of the ranks in the smaller sample group or from the first 
selected group when both groups are of the same size. This value was compared to the 
population of all possible rankings in order to determine the occurrence of T). For paired 
comparison of non-parametric data, Wilcoxon Sign Rank test was applied; the Wilcoxon test 
statistic W was computed by ranking all the differences before and after the treatment based 
on their absolute value, then attaching the signs of the difference to the corresponding ranks.  
The signed ranks were then summed and compared. Concerning association analysis, 
statistical significance was assessed with the Pearson Product Moment Correlation 
Coefficient. The Kolmogorov-Smirnov test was used to assess statistical significance for 
probability distribution. Two groups of data were considered statistically different if P ≤ 
0.05. 
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Results 
 
1. H2O2: an oxidative challenge to HMs 
1.1 Application of H2O2 induced changes in HM electrophysiological 
characteristics 
Bath-applied H2O2 (1 mM; 30 min) increased HM input resistance that, on average, rose from 
383±32 MΩ to 408±37 MΩ when measured on the same neurons before and after application 
(Student’s t-test, t5 = 3.922, P = 0.011, n = 6). Fig. 17 A shows, for each cell, normalized 
data for such a input resistance change that on average was 6±1 % (Wilcoxon Signed Rank 
Test, W = -21.00, P = 0.031, n = 6). This effect could not be reversed even after prolonged 
(30 min) washout in four cells, while it was reversible in two of them. Comparable tests run 
for analogous length of time did not indicate a gradual rise in input resistance under control 
conditions. The example of Fig. 17 A (inset) indicates that the slope of the linear plot of the 
current/voltage relation is decreased with extrapolated crossover at -93 mV. The rise in input 
resistance was accompanied by the onset of an inward current reaching its maximum at ≥ 15 
min (-98.3±25.5 pA Ipeak versus -53.3±10.2 pA baseline, Student’s t-test, t5 = -2.773, P = 
0.039, n = 6; Fig. 17 B) corresponding to a 76±19 % change. Even if the current increase 
tended to fade towards the end of H2O2 application, the inward current amplitude (residual 
current; Ires) was still significantly augmented (61±21 %) when compared to control condition 
(-88.7±21.7 Ires versus -53.3±10.2 pA, Student’s t-test, t5 = -2.576, P = 0.050, n = 6; Fig. 17 
B) with poor recovery on washout (-85.0±22.6 pA). Furthermore, 1 mM H2O2 induced global 
depression of spontaneous postsynaptic currents frequency (0.58±0.15 Hz versus 1.75±0.49 
Hz control, Student’s t-test, t5 = -3.403, * P = 0.019, n = 6), that persisted even after washout 
(0.41±0.19 Hz, Student’s t-test, t5 = -3.784, # P = 0.013, n = 6; see histograms & sample 
traces in Fig. 1 C). Conversely, there was no significant change in event amplitude caused by 
H2O2 (-48.5±5.3 control versus -33.8±5.9 pA in H2O2 solution; Student’s t-test, t5 = 2.192, P 
= 0.080, n = 6).   
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Fig. 17. HM electrophysiological characteristics after application of 1 mM H2O2. (A) 
Increased input resistance observed in voltage-clamp configuration after H2O2 application 
(Student’s t-test, t5 = 3.922, P = 0.011, n = 6; 6±1 %, Wilcoxon Signed Rank Test, W = -
21.00, P = 0.031, n = 6). Each line represents an individual neuron. Inset shows example of 
current ⁄ voltage plot in control (filled circles) or during application of H2O2 (open circles). 
Note decreased slope of the linear portion of the plot with extrapolated crossover at -93 mV. 
(B) H2O2 caused an inward current reaching its maximum value at ≥ 15 min (H2O2 Ipeak, 
76±19 %, n = 6), the effect was maintained for the length of H2O2 bath application (residual 
current following H2O2, Ires, 61±21 %, n = 6). Each line represents an individual neuron. (C) 
Fall in spontaneous synaptic events frequency after application of H2O2 (Student’s t-test, t5 = 
-3.403, * P = 0.019, n = 6). This effect was not reversible even after prolonged washout 
(Student’s t-test, t5 = -3.784, # P = 0.013, n = 6). Inset (right) shows example of depression of 
synaptic event frequency by H2O2 with poor recovery on washout. w.o., washout. 
 
1.2 Relative contribution by excitatory and inhibitory synaptic transmission to 
the effects of H2O2 
Synaptic depression evoked by H2O2 might have had a complex origin which we attempted to 
investigate by studying whether H2O2 modulated release of the excitatory transmitter 
glutamate (O’Brien et al., 1997; Essin et al., 2002) or of the inhibitory transmitters GABA 
and glycine (Donato & Nistri, 2000). To explore any direct action, we blocked 
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premotoneuron activity with TTX and looked at the effects of H2O2 on motoneuron intrinsic 
properties and release mechanisms. Table 1 shows that, although TTX per se did not change 
control input resistance (Student’s t-test, t4 = 0.706, P = 0.519, n = 5), it slightly reduced the 
baseline holding current (Student’s t-test, t4 = 4.921, * P = 0.004, n = 5) indicating a tonic 
contribution by synaptic transmitter release to the baseline current.  
 
Table 1. Average change in input resistance and baseline current induced by application of 
TTX 
 
Input resistance, MΩ 
Control 183±19 
TTX 191±25 
Statistics Student’s t-test, t4 = 0.706,            
P = 0.519, n = 5 
Baseline current, pA 
Control -94.2±19.2 
TTX -51.7±14.1 * 
Statistics Student’s t-test, t4 = 4.921,                
* P = 0.004, n = 5 
 
Fig. 18 A, B illustrates the persistence of the effect of H2O2 on input resistance (293±35 MΩ 
versus 208±20 MΩ TTX, Student’s t-test, t5 = 3.176, * P = 0.025, n = 6) and baseline holding 
current (-91.6±15.3 pA Ipeak versus -56.6±14.0 pA TTX, Student’s t-test, t5 = -3.130, # P = 
0.026, n = 6; -77.5±15.9 pA Ires, Student’s t-test, t5 = -2.751,   P = 0.040, n = 6) after 
blocking ionotropic glutamate receptors with APV (50 µM) and CNQX (10 µM). 
Unexpectedly, H2O2 significantly enhanced mIPSC frequency (3.19±0.59 Hz versus 
1.55±0.26 Hz TTX, Student’s t-test, t5 = 3.383, ♦ P = 0.015, n = 6; Fig. 18 C) without 
changing their amplitude (-34.3±4.8 pA versus -28.6±2.4 pA TTX, Student’s t-test, t5 = -
1.200, P = 0.275, n = 6; Fig. 18 D).  
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Fig. 18. H2O2-induced electrophysiological changes were insensitive to glutamatergic 
blockers. (A) In the presence of d-amino-phosphonovalerate (APV; 50 µM) and 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX; 10 µM), H2O2 increased HM input resistance, an effect 
not reversible even after prolonged washout (Student’s t-test, t5 = 3.176, * P = 0.025 for 
H2O2 vs. control; t5 = 2.664, ♣ P = 0.045 for w.o. vs. control, n = 6). (B) APV and CNQX 
did not alter the effect of H2O2 on inward current amplitude that rose during the application, 
reached a maximum value (H2O2 Ipeak, Student’s t-test, t5 = -3.130, # P = 0.026, n = 6), and 
persisted for the duration of the treatment (H2O2 Ires; Student’s t-test, t5 = -2.751, ♠ P = 0.040, 
n = 6). (C) H2O2 significantly increased miniature inhibitory postsynaptic current (mIPSC) 
frequency (Student’s t-test, t5 = 3.383, ♦ P = 0.015, n = 6). (D) mIPSC amplitude did not 
change following H2O2 (Student’s t-test, t5 = -1.200, P = 0.275, n = 6). (E) Time course of 
changes in HM holding current (Vh = -65 mV). Tetrodotoxin (TTX) ⁄ APV ⁄ CNQX 
application caused a slight outward current (filled arrow); note slowly developing inward 
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current following H2O2 superfusion (red arrow) that reached its maximum after 15 min 
treatment (asterisk). The inward current persisted for the length of H2O2 application (30 min), 
although it slowly declined. (F) Time course of mIPSC frequency during TTX ⁄ APV ⁄ CNQX 
and H2O2 application shows biphasic rise with recovery on washout. Arrows and asterisks 
correspond to record sections indicated in E. (G) Plot of cumulative probability distribution 
of mIPSC amplitude that was shifted to the right by 1 mM H2O2 (dashed line). In TTX ⁄ APV 
⁄ CNQX condition, the cumulative probability plot comprised 154 events, while after H2O2 it 
included 365 events. w.o., washout. 
 
Fig. 18 E, F exemplifies the timecourse of changes in holding current and mIPSP frequency 
during H2O2 application: after the slight outward current and fall in event frequency observed 
with the administration of TTX, CNQX and APV (filled arrow), superfusion with H2O2 (red 
arrow) elicited a slow increase in holding current (peaking at 15 min, asterisk) together with 
a large rise in event frequency, thereafter the holding current faded, despite the persistently 
high event frequency that was attenuated on washout. Fig. 18 G shows that the action of 
H2O2 consisted in broad increase in the probability of event detection without affecting 
threshold or maximum. These data, thus, suggest that H2O2 not only caused an inward 
(depolarizing) current, but it also facilitated inhibitory transmitter release through apparently 
distinct mechanisms.  
Parallel tests done after block of glycine and GABA receptors with 0.4 μM strychnine and 10 
μM bicuculline (Donato & Nistri, 2000) indicated that H2O2 significantly increased input 
resistance (263±40 MΩ versus 227±30 MΩ TTX, Student’s t-test, t5 = 2.396, * P = 0.043, n 
= 6; Fig. 19 A). However, as exemplified in Fig. 20, under these conditions, there was no 
significant change in baseline holding current (-51.7±7.4 pA Ipeak versus -42.5±6.9 pA TTX, 
Student’s t-test, t5 = -2.015, P = 0.100, n = 6; -50.8±6.8 pA Ires, Student’s t-test, t5 = -2.076, P 
= 0.093, n = 6; Fig. 19 B). While the frequency of mEPSCs is usually low (Quitadamo et al., 
2005; Lamanauskas & Nistri, 2008), H2O2 evoked a significant event frequency increase that, 
on average, was 0.93±0.16 Hz (versus 0.58±0.08 Hz in control, Student’s t-test, t5 = 3.130, # 
P = 0.014, n = 6; Fig. 19 C) without altering their amplitude (-12.6±0.9 pA versus -15.0±1.2 
pA TTX, Student’s t-test, t5 = 2.252, P = 0.054, n = 6; Fig. 19 D). Fig. 19 E, F shows that 
H2O2 induced a leftward parallel shift in the event probability plot, and that the largest 
number of events appeared in the amplitude region of -8 to -12 pA (without changes in 
holding current; Fig. 20).   
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Fig. 19. Contribution of GABAergic and glycinergic transmission to H2O2 effects on 
HM electrophysiological properties. (A) In the presence of bicuculline (10 µM) and 
strychnine (0.4 µM), H2O2 could enhance HM input resistance (Student’s t-test, t5 = 2.396, * 
P = 0.043, n = 6). (B) Blockers of GABAA and glycine receptors prevented the effect of H2O2 
on baseline inward current (Student’s t-test; H2O2 Ipeak, t5 = -2.015, P = 0.100; H2O2 Ires, t5 = -
2.076, P = 0.093; n = 6). (C) In the presence of TTX, H2O2 enhanced mEPSC frequency 
(Student’s t-test, t5 = 3.130, # P = 0.014, n = 6) without changing mEPSC amplitude (D; 
Student’s t-test, t5 = 2.252, P = 0.054, n = 6). (E) Plot of cumulative probability distribution 
of mEPSC amplitude was shifted to the left by H2O2 application (dashed line). In 
TTX/bicuculline/strychnine solution, the cumulative probability plot comprised 67 events, 
while after H2O2 it included 143 events. (F) Histograms showing mEPSC amplitude 
distribution before and after H2O2 treatment; data are from the same cell shown in E. 
 
 
Fig. 20. Example of baseline current recorded (under voltage clamp) from HM in the 
continuous presence of TTX (1 µM), bicuculline (bic; 10 µM) and strychnine (strych; 0.4 
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µM) as indicated by the black horizontal bar. Red bar indicates application of H2O2 that did 
not change baseline current. Vh is the holding potential. 
 
These data suggest that miniature excitatory synaptic transmission was also facilitated by 
H2O2 even though the frequency of such events was smaller than the one of inhibitory events. 
The consistent facilitation of mIPSCs and mEPSCs by H2O2 might have been due to a large 
rise in intracellular free Ca2+ to promote transmitter release under resting conditions. Table 2 
shows that H2O2 significantly enhanced global frequency of miniature events (Student’s t-
test, t4 = 3.706, P = 0.021, n = 5), an effect mimicked by thapsigargin (1 μM, Student’s t-test, 
t4 = 2.932, P = 0.043, n = 5) that, by blocking Ca2+ store pumps, is known to increase 
intracellular Ca2+ (Kirby et al., 1992; Reyes & Stanton, 1996; Takahashi et al., 2007; Table 
2).  
 
Table 2. Similar effects of H2O2 and thapsigargin on miniature events frequency 
  Miniature 
frequency, Hz 
 
 
Student’s t4 
value P - value n 
 
TTX 
 
0.54±0.08 
 
3.706 
 
0.021 
 
5 
TTX + H2O2 2.33±0.54    
     
TTX 0.34±0.05 2.932 0.043 5 
TTX + thapsigargin 0.99±0.27    	  
1.3 H2O2 treatment modulated persistent Na+ and Ca2+ currents 
Our experiments indicated how H2O2 affected synaptic transmission and intrinsic properties 
of HMs, but they did not show if there were also changes in excitability within the membrane 
potential region of repeated HM firing. Previous studies have shown that persistent inward 
currents (PICs) expressed by the soma of HMs (Moritz et al., 2007) contribute to integration 
of motoneuron signals for patterned output (Brownstone, 2007), and are mediated by 
sustained influx of Na+ and ⁄ or Ca2+ (Crill, 1996; Russo & Hounsgaard, 1999). Because 
persistent Na+ conductance - PIC(Na) - is reported to be increased in motoneurons of  the 
presymptomatic ALS genetic mouse model (Kuo et al., 2005; van Zundert et al., 2008), we 
explored the possibility that H2O2 could affect PICs using a slow ramp protocol (see top 
schemes in Fig. 21 A, B). In accordance with previous studies (Crill, 1996; Russo & 
Hounsgaard, 1999; Lamanauskas & Nistri, 2008), we assumed that the Mn2+-sensitive 
component represented the persistent Ca2+ conductance - PIC(Ca) - while the TTX-sensitive 
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component represented PIC(Na). Fig. 21 A shows an example of global PIC observed in 
control conditions (Krebs). This response (attenuated by 1 µΜ TTX to pharmacologically 
isolate PIC(Ca)) was largely inhibited by H2O2 (1 mM; 30 min) as indicated by the 
superimposed traces of the current responses in the inset to Fig. 21 A. Average data are given 
in Table 3.  
 
Fig. 21. Voltage-activated PICs were modulated by H2O2. (A) On HMs, voltage ramps 
(from -80 to +20 mV; rate = 21 mV ⁄ s; see top scheme) induced PICs (mediated by Na+ and 
Ca2+; see arrow) followed by a large outward current in control solution (Krebs). TTX (1 µM) 
was applied to pharmacologically isolate PIC(Ca) (Crill, 1996; Russo & Hounsgaard, 1999). 
After H2O2 application, PIC(Ca) was depressed as indicated by the superimposed traces of the 
current responses in the inset. (B) PIC(Na) current, isolated after PIC(Ca) block with 2 mM 
Mn2+, was also reduced following application of H2O2. The superimposed records in the inset 
depict the reduction (larger current and time bars). Calibrations in inset to A apply also to 
inset to B. 
 
In a separate set of experiments we applied 2 mM Mn2+ to measure PIC(Na) in isolation (Fig. 
21 B). Adding Mn2+ reduced the amplitude of the global PIC and disclosed PIC(Na) that, 
following H2O2 application, was decreased as depicted by the superimposed records in the 
inset to Fig. 21 B. Summary data from these tests with Mn2+ are shown in Table 3. On 
average, it appears that H2O2 decreased PIC(Ca) amplitude and area by 79 %, while the 
corresponding falls in PIC(Na) amplitude and area were 38 % and 50 %, respectively, 
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without any significant variation of activation thresholds. We did not observe recovery in the 
PIC(Na) or PIC(Ca) amplitude after washout. 
 
Table 3. Persistent inward currents in the presence of H2O2 
 
 Amplitude, pA Area, pA\ms Threshold, mV 
PIC 209 ± 26 * 231 ± 41   -60.9 ± 1.2 
PIC(Ca) 97 ± 16 # 81 ± 16 ♥ -55.4 ± 3.2 
PIC(Ca) after H2O2 21 ± 5   17 ± 5 ♣ -56.5 ± 2.3 
 
n = 7 for all cases. Amplitude: t6 = -3.395, P = 0.015 for # vs. *; t6 = -4.860, P = 0.003 for   
vs. #; Area: t6 = -3.106, P = 0.021 for ♥ vs.  ; t6 = -3.969, P = 0.007 for ♣ vs. ♥; Threshold: 
t6 = 1.857, P = 0.122 for PIC(Ca) vs. PIC; t6 = -0.346, P = 0.743 for PIC(Ca) after H2O2 vs. 
PIC(Ca).   
 
 Amplitude, pA Area, pA\ms Threshold, mV 
PIC 127 ± 22 * 133 ± 28   -60.4 ± 1.5 
PIC(Na) 72 ± 15 # 74 ± 15 ♥ -56.8 ± 2.5 
PIC(Na) after H2O2 45 ± 15   37 ± 12 ♣ -57.4 ± 2.3 
 
n = 5, Amplitude: t4 = -6.835, P = 0.002 for # vs. *; t4 = -3.056, P = 0.038 for   vs. #; Area: 
t4 = -4.164, P = 0.014 for ♥ vs.  ; t4 = -5.421, P = 0.006 for ♣ vs. ♥; Threshold: t4 = 2.640, P 
= 0.058 for PIC(Na) vs. PIC; t4 = -0.535, P = 0.621 for PIC(Na) after H2O2 vs. PIC(Na).  
Symbols refer to Student’s t-test comparison between data pairs.  
  
1.4 Hyperexcitability of HMs treated with H2O2 
The PIC inhibiting ability of H2O2 was surprising in view of the reported hyperexcitability of 
motoneurons from presymptomatic ALS genetic models (Kuo et al., 2005; van Zundert et al., 
2008). Hence, we investigated whether H2O2 might influence rat HM firing properties. Fig. 
22 A shows an example of HM responses to bath applied H2O2 at resting membrane potential 
(Vm) of -65 mV (on average, initial Vm was -63±1 mV; n = 26). Following application of 
H2O2, there was gradual membrane depolarization (7 mV; on average, Vm after H2O2 was -
59±1, Student’s t-test, t25 = 5.186, P ≤ 0.001, n = 26) that persisted during washout. We used 
rectangular current pulses to induce repeated firing and to detect the sensitivity of spike 
activity to H2O2. Current steps (300 pA for 500 ms) injected into HMs evoked firing as 
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exemplified in Fig. 22 A, B. In control condition, this motoneuron fired 14 spikes (Fig. 22 B, 
left trace), while, during H2O2 application, the HM (repolarized to the original Vm), 
responded with 26 spikes superimposed on the larger amplitude of the membrane voltage 
change (Fig. 22 B, right trace). The example of Fig. 22 C shows a plot of instantaneous firing 
frequency versus time (during the 500 ms pulse) in control (filled circles) or in the presence 
of H2O2 (open circles). There was an upward shift of the graph that was best fitted with 
double exponential (τ1 and τ2) decay (in accordance with the study by Sawczuk et al., 1995) 
with values of 0.01 s τ1 and 8.33 s τ2 for control, and 0.02 s τ1 and 11.11 s τ2 for H2O2 
treatment. The adequacy of the fit was confirmed by the correlation values r = 0.9980 and 
0.9925 for control and H2O2, respectively. 
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Fig. 22. Changes in HM excitability induced by H2O2. (A) Examples of responses of HM 
to bath applied H2O2. Trace is a continuous, slow record of a cell with initial Vm of -65 mV. 
Segments of this trace are also shown on a faster time base to depict spike firing evoked by 
intracellular injection of 300 pA (500 ms). Note that, following application of H2O2, there is 
gradual membrane depolarization (7 mV) associated with enhanced spike activity (when the 
Vm is repolarized back to rest). Prolonged washout was not able to reverse the observed 
effects. (B) Fast time base example of evoked firing (300 pA; 500 ms) in control and after 
H2O2 application. Note the higher number of spikes and the larger amplitude of the 
membrane voltage response to the same current injection pulse following H2O2. (C) Example 
of instantaneous firing frequency in control (filled symbols) and following H2O2 application 
(open symbol). Data are fitted with double exponential function in accordance with Sawczuk 
et al. (1995). (D) Plot of average (n = 6 cells) interspike interval (isi) versus spike interval in 
the 500 ms train. Data were fitted with a cubic polynomial function (see methods) and the 
curves difference integral for the first 13 spikes calculated. Subtraction of the treated area 
(open circles) from control (filled circles) gave ∫113 (y1 - y2) = 0.6141, indicating the change 
evoked by H2O2. Control area was ∫113 y1 = 1.1206. After normalization, the H2O2-mediated 
decrease in area was equal to 0.6141/ 1.1206 * 100 = 55 %. (E) Scatter plot of the AHP 
amplitude versus the number of evoked spikes in control condition (filled symbols) and 
following H2O2 bath application (open symbols). AHP amplitude was measured at the end of 
a 300 pA depolarizing current pulse, applied at the same Vm before and after H2O2 treatment 
(n = 13). In control condition, the AHP amplitude increased with the number of evoked 
spikes (regression equation: y = 0.08 x + 0.50; r = 0.895; P ≤ 0.001). In the presence of H2O2 
the linear relation was lost (r = 0.437; P = 0.135) and, despite the larger number of action 
potentials, the AHP amplitude was decreased (Student’s t-test, t12 = 2.335, P = 0.038, n = 
13). The inset shows that, at -65 mV, superimposed AHPs (evoked by 20 spikes) were 
markedly different between control (1.70 mV; black trace) and H2O2 solution (0.45 mV; red 
trace). 
 
Fig. 22 D demonstrates that, on 6 cells held at the same membrane potential (-65 mV), there 
was a relatively consistent interspike interval value throughout the firing phase when H2O2 
was applied (open circles; see Lape and Nistri, 2000), unlike the complex changes detected 
prior to the treatment. Using the function described in the methods for fitting data of Fig. 22 
D, we observed a 55 % area difference between controls and H2O2-treated responses.  
Averaging out data for 26 HMs showed that H2O2 significantly enhanced the mean firing 
frequency (45±2 Hz versus 31±2 Hz, Student’s t-test, t25 = 9.588, P ≤ 0.001, n = 26). This 
phenomenon was accompanied by a significant rise in input resistance (179±15 MΩ versus 
128±9 MΩ control; Student’s t-test, t25 = 4.986, P ≤ 0.001, n = 26). Table 4 shows that H2O2 
increased input resistance, spike firing and evoked membrane depolarization even when 
applied in the presence of APV and CNQX, or bicuculline and strychnine, suggesting that 
these effects were, at least in part, due to a direct action on HMs. 
 
Table 4. Changes in input resistance, average firing frequency and membrane potential 
evoked by H2O2 in standard solution or in the presence of blockers of glutamatergic 
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transmission (CNQX and APV) or inhibitory synaptic transmission (bicuculline and 
strychnine). 
 
 Input resistance 
MΩ 
Firing frequency 
Hz 
Membrane potential 
mV 
Control 117±15 17±4 -63±1 
H2O2 169±16 * 33±5 * -56±2 * 
Statistics Student’s t-test, 
t5 = 5.234,              
* P = 0.003,      
n = 6  
Student’s t-test,  
t5 = 5.237,                
* P = 0.003,        
n = 6  
Student’s t-test,           
t5 = 6.740,                    
* P = 0.001,                 
n = 6  
APV+CNQX 138±17 32±3 -62±1 
APV+CNQX+ H2O2 203±30 * 46±2 * -60±2 * 
Statistics Student’s t-test, 
t9 = 3.627,              
* P = 0.006,      
n = 10  
Student’s t-test,  
t9 = 5.659,                
* P ≤ 0.001,        
n = 10  
Student’s t-test,           
t9 = 2.473,                    
* P = 0.035,                 
n = 10  
Bic+Strych 128±7 36±3 -64±1 
Bic+Strych+H2O2 162±13 * 49±4 * -61±1 * 
Statistics Student’s t-test, 
t9 = 2.729,              
* P = 0.020,      
n = 10  
Student’s t-test,  
t9 = 5.180,                
* P ≤ 0.001,        
n = 10  
Student’s t-test,           
t9 = 5.842,                    
* P ≤ 0.001,                 
n = 10 
 
Ca2+-activated K+ conductances responsible for the spike afterhyperpolarization (AHP) are 
activated by PIC(Ca) in rat motoneurons (Li & Bennett, 2007) and powerfully modulate the 
cell excitability (Rekling et al., 2000b; Kuo et al., 2005). Since our results demonstrated that 
H2O2 induced a preferential reduction of PIC(Ca) associated with hyperexcitability in rat 
HMs, we wondered if these effects could be explained by decreased AHP amplitude by H2O2. 
Thus, we measured the amplitude of the slow AHP at the end of the 300 pA depolarizing 
current pulse (at the same Vm before and during H2O2 application) and correlated it to the 
number of spikes (Fig. 22 E, n = 13). In control condition (filled symbols), there was the 
expected linear relation between the AHP amplitude and the spikes number (r = 0.895, P ≤ 
0.001). In the presence of H2O2 (Fig. 22 E, open symbols), not only this relation was lost (r = 
0.437, P = 0.135), but the AHP amplitude was reduced in spite of augmented firing 
(1.39±0.24 mV versus 1.96±0.18 mV control, Student’s t-test, t12 = 2.335, P = 0.038, n = 13). 
The inset to Fig. 22 E shows that, at -65 mV, superimposed AHPs (evoked by 20 spikes) 
were markedly different in amplitude between control (1.70 mV; black trace) and H2O2 
solution (0.45 mV; red trace).   
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1.5 H2O2 was effective in inducing oxidative stress damage to HMs 
To demonstrate the HM redox stress induced by 1 mM H2O2, we used dihydrorhodamine 
123, a non-fluorescent and lipophilic molecule that, by oxidation, yields the fluorescent 
probe rhodamine 123 (Sánchez-Carbente	  et al., 2005; Jiang et al., 2006). Fig. 23 A compares 
confocal images of intracellular generation of reactive oxygen species (ROS, red 
pseudocolour) following incubation (for 30 min) in Krebs solution (top, left) or H2O2 
(bottom, left). Hoechst 33342 was used as a cell counterstain (blue pseudocolour). Note that, 
despite the analogous number of Hoechst positive cells in either condition, the number of 
rhodamine 123 positive cells (with >25 µm soma) was higher following H2O2. These 
observations are quantified in the histograms of Fig. 23 B in which the confocal images 
throughout the slices were reconstructed in 3D and the rhodamine signal expressed as 
fraction of the Hoechst 33342 one (0.26±0.04 versus 0.13±0.05, Mann-Whitney Rank Sum 
Test, T = 489.00, * P = 0.002, n = 5 rats). 
 
Fig. 23. Oxidative stress of HMs caused by H2O2. (A) Histological example of rhodamine 
123 staining of cells in hypoglossal slices incubated for 30 min in Krebs solution or in the 
presence of H2O2 (1 mM). After rinsing, cells were stained with dihydrorhodamine 123 (red 
pseudocolour) to reveal intracellular oxidative processes (Sánchez-Carbente	   et al., 2005; 
Jiang et al., 2006) and Hoechst 33342 (blue pseudocolour) to show cell nuclei. Note that, 
notwithstanding the analogous number of Hoechst positive cells, there was a larger number 
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of rhodamine 123 positive, large soma cells following H2O2. (B) Histograms show the ratio 
of rhodamine positive cells over Hoechst positive cells, indicating a significant rise after 
H2O2. Data are from 5 animals and were quantified with ImageJ software (Mann-Whitney 
Rank Sum Test, T = 489.00, * P = 0.002). 
  
1.6 H2O2 did not alter short-term cell survival 
Since H2O2 application was accompanied by increased intracellular oxidative processes, we 
next addressed the question whether this phenomenon actually affected HM survival. First, 
we investigated the consequence of H2O2 application on the global hypoglossal nucleus cell 
population (Kitamura et al., 1983; Boone & Aldes 1984; Viana et al., 1990) in unfixed 
specimens using the nuclear dye PI, which penetrates into cells only after membrane 
disruption (Kristensen et al., 2001; Bonde et al., 2003; Babot et al., 2005; Bösel et al., 2005). 
The total number of cells (intact as well as damaged) within each hypoglossal nucleus section 
was estimated with Hoechst 33342. Fig. 24 A shows staining with PI and Hoechst 33342 
within the nucleus hypoglossus after incubation in Krebs solution (left) or after applying 
H2O2 for 30 min (top right) or 1 h (bottom right). In each example there was presence of co-
staining, indicating a degree of cell damage in control or after treatment. Quantification of 
these observations (Fig. 24 B) demonstrates that after either 30 min or 1 h application of 
H2O2 there was no significant increase in cell death (Mann-Whitney Rank Sum Test, T = 
1283.00 or 919.00, P = 0.240 or 0.202 for 30 min or 1 h, respectively, n = 8 rats). Likewise, 
analysis of HM numbers with the motoneuron marker SMI 32 (Fig. 24 C), a monoclonal 
antibody against the non-phosphorylated form of neurofilament H (Jacob et al., 2005; Raoul 
et al., 2005), confirmed similar presence in control (Krebs, left) or after H2O2 application 
(right). The histograms of Fig. 24 D related to the sampled area (see inset to Fig. 24 D) 
indicate that, on average, H2O2 did not change the number of HMs within the nucleus 
hypoglossus (53±1 versus 50±4, Mann-Whitney Rank Sum Test, T = 25.00, P = 0.690, n = 5 
rats). 
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Fig. 24. H2O2 did not alter short-term cell survival. (A) Examples of fluorescence cell 
counts after staining with PI, a DNA dye that labels membrane-damaged cells (red 
pseudocolour), and Hoechst 33342 (blue pseudocolour) in two experimental protocols: Krebs 
versus either 30 min H2O2 (top row) or 1 h H2O2 (bottom row). In each panel, PI positive 
cells are indicative of dead cells. (B) Histograms showing no increase in cell death after 
exposure to either 30 min H2O2 or 1 h H2O2 (control value comprises cells damaged by the 
brain-slicing preparation). Data (collected from 8 rats) were quantified with ImageJ software 
and expressed as ratio of PI positive cells over Hoechst positive cells. Mann-Whitney Rank 
Sum Test gave T = 1283.00, P = 0.240 for the difference between Krebs and 30 min H2O2; T 
= 919.00, P = 0.202 for the difference between Krebs and 1 h H2O2. (C) Example of confocal 
images of HMs labeled with the motoneuron marker SMI 32 (Jacob et al., 2005; Raoul et al., 
2005) in control condition and after 30 min H2O2 (the red box is the sample area used to 
count HMs). (D) Left, scheme of sampled area used for confocal images, shown in red within 
one nucleus hypoglossus. Right, histograms quantifying the number of HMs (SMI 32 
positive) with no significant difference between control and H2O2 treatment. Data were 
quantified with CellCounter (Mann-Whitney Rank Sum Test, T = 25.00, P = 0.690, n = 5 
rats). 
 
1.7 ATF-3 expression by HMs treated with H2O2  
The dissociation between intracellular redox stress and unchanged survival of HMs after 
H2O2 application, led us to look for a biomarker that could signal motoneuron damage. For 
this purpose, we used ATF-3, a member of the ATF ⁄ CREB family of transcription factors, 
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whose expression has been shown to rise after injurious stimuli (Tsujino et al., 2000; Hai & 
Hartman, 2001; Vlug et al., 2005). Fig. 25 A shows staining by ATF-3 (bottom) or SMI 32 
(top) of hypoglossal nuclei fixed 1 h after washout of 1 mM H2O2 (right) or control solution 
(left). While the total number of HMs (SMI 32 immunopositive cells) was comparable 
between control (Krebs) and after H2O2, HMs expressing ATF-3 were more frequently 
detected in slices treated with H2O2. We next quantified the simultaneous occurrence of SMI 
32 and ATF-3 within the same HMs. For this purpose we expressed co-staining for these 
markers as covariance values (see methods). Fig. 25 B summarises these observations: 
whereas in Krebs solution the covariance value between ATF-3 and SMI 32 fluorescence 
was 139±50, this value significantly increased to 434±128 in the presence of H2O2 (Mann-
Whitney Rank Sum Test, T = 46.00, * P = 0.021, n = 8 rats). 
 
Fig. 25. ATF-3 expression by HMs treated with H2O2. (A) Examples of SMI 32 (top) and 
ATF-3 (bottom) immunoreactivity of nucleus hypoglossus in control (left) and after H2O2 
(right). Note that, despite a similar number of HMs (SMI 32 positive), ATF-3 staining was 
highly enhanced following H2O2. ATF-3, a member of the ATF ⁄ CREB family of 
transcription factors, is proposed to be a marker of neuronal injury (Tsujino et al., 2000; Hai 
& Hartman, 2001; Vlug et al., 2005). (B) Histograms show the covariance between ATF-3 
staining and SMI 32 staining, indicating a significant rise after H2O2. Data are from 8 animals 
and were quantified with MATLAB 7.1 software (Mann-Whitney Rank Sum Test, T = 46.00, 
* P = 0.021). 
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1.8 H2O2 did not alter S100B immunoreactivity of protoplasmic astrocytes 
In ALS non-neuronal cells play key roles in disease etiology and loss of motoneurons 
(Clement et al., 2003; Boillée et al., 2006). Therefore, our aim was to investigate whether 
astroglial cells were affected by H2O2 application.  
The anti-S100 polyclonal antibody targets the S100B calcium binding protein found in the 
cytoplasm and nucleus of protoplasmic astrocytes (see Material & Methods). Former studies 
have reported changes in S100B immunoreactivity in association with brain damage and 
degenerative brain disease including ALS (Migheli et al., 1999; Rothermundt at al.; 2003; 
Blackburn et al., 2009). Fig. 26 A shows that 30 min application of H2O2 did not change 
S100B immunolabeling in the nucleus hypoglossus as compared to control slices. 
Quantification of S100B immunopositive cells is shown in the histograms of Fig. 26 B 
(63±3, control; 59±2, H2O2; Student’s t-test, t32 = 0.938, P = 0.355, n = 3 rats).  
This observation suggests that the oxidative challenge exerted by H2O2 did not produce early 
damage to astroglia in the nucleus hypoglossus. 
 
 
Fig. 26. S100B immunolabeling in the nucleus hypoglossus after H2O2 treatment. (A) 
Examples of confocal microscopy images showing  S100B+SMI 32 (top row; red and green 
pseudocolors, respectively) and Hoechst 33342 (bottom row; gray pseudocolor) 
immunoreactivity of nucleus hypoglossus after 30 min incubation in control (left), or 1 mM 
H2O2 (right). Note that S100B immunoreactivity was also present in ependymal cells (see 
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Material & Methods). (B) Histograms quantify the number of cells positive to both S100B 
and Hoechst 33342 staining (identified as protoplasmic astrocytes, see Material & Methods) 
in both conditions. Data were quantified with ImageJ software (Student’s t-test, t32 = 0.938, P 
= 0.355, n = 3 rats). 
 
2. Sodium nitroprusside and nitrosative stress 
2.1 HM electrophysiological changes induced by NaNP treatment 
Nitric oxide (NO) is a well-known signaling molecule, identified more than two decades ago 
as an endothelium-derived relaxing factor (Palmer et al., 1987; Furchgott, 1999) with potent 
vasodilator activity. Since then, increasing numbers of biochemical pathways have been 
shown to be modulated by NO. Imbalance of NO signaling has also been linked to different 
human diseases. In particular, increasing evidence suggests that S-nitrosylation is involved in 
the pathogenic process of various neurodegenerative disorders like ALS (Beal et al., 1997). 
Thus, we decided to investigate the effect of nitrosative stress on HM by bath-applying 500 
µM sodium nitroprusside (NaNP), a NO donor (Southam & Garthwaite, 1991; Dawson et al., 
1993; Liu & Martin, 2001; Hall et al., 2009).  
Fig. 27 A shows an example of HM response (Vh = -60 mV) to bath applied NaNP (500 µM). 
Following application of the NO donor, there was the onset of an outward current which 
stabilized at plateau within ≈ 1 min. This outward current lasted throughout the treatment 
(usually 30 min), with no recovery on washout. On average, baseline current was -117±18 
pA in control, -68±10 pA after both NaNP treatment and washout (Student’s t-test, t9 = -
4.396, * P = 0.002 for NaNP versus control; t9 = -3.741, # P = 0.005 for w.o. versus control; 
n = 10; Fig. 27 B). The change in baseline current was accompanied by a rise in input 
resistance (250±35 MΩ versus 206±30 MΩ control, Student’s t-test, t9 = 2.629, * P = 0.027, 
n = 10; Fig. 27 C). Furthermore, 500 µM NaNP induced global depression of spontaneous 
postsynaptic currents frequency (1.12±0.18 Hz versus 2.06±0.46 Hz control, Student’s t-test, 
t9 = -2.341, * P = 0.047, n = 10), with partial recovery on washout (1.57±0.38 Hz, Student’s 
t-test, t9 = -1.273, P = 0.239, n = 10; see histograms in Fig. 27 D). Fig. 27 E shows the 
distribution of synaptic events peak amplitude in control and following NaNP: the Gaussian 
distribution characteristic of the control condition was skewed to the left following the 
treatment as a result of the prevalence of small amplitude events. The cumulative plot in Fig. 
27 F demonstrates that the probability of observing slowly decaying events increased after 
NaNP application. Even though it is necessary to investigate this phenomenon further, the 
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analysis suggests that synaptic activity depression was mainly concerned with fast, large 
events. 
 
Fig. 27. HM electrophysiological characteristics after application of 500 µM NaNP. (A) 
Sample record under voltage clamp configuration (Vh = -60 mV) showing the onset of an 
outward current rapidly stabilizing following the application of NaNP, with no recovery on 
washout. (B) Histograms quantify the HM baseline current in control, following NaNP, and 
in washout (Student’s t-test, t9 = -4.396, * P = 0.002 for NaNP versus control; t9 = -3.741, # P 
= 0.005 for w.o. versus control; n = 10). (C) Histograms showing an increase in HM input 
resistance following NaNP application (Student’s t-test, t9 = 2.629, * P = 0.027, n = 10). (D) 
Histograms quantify the global depression of spontaneous postsynaptic currents frequency 
(Student’s t-test, t9 = -2.341, * P = 0.047, n = 10). (E) Histograms showing spontaneous 
synaptic events amplitude distribution before and after NaNP treatment. The analysis 
comprised 361 events; different cell from (A). (F) Plot of cumulative probability distribution 
of spontaneous synaptic events decay time that was shifted to the right by 500 µM NaNP (red 
dashed line). The analysis comprised 457 events; data are from the same cell shown in E.  
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2.2 NaNP treatment modulated persistent inward currents (PICs) 
We investigated the possibility that NaNP could affect PICs using a slow ramp protocol (see 
top scheme in Fig. 28). Fig. 28 shows an example of global PIC observed in control 
conditions (Krebs). This response was inhibited by NaNP (500 µM; 30 min) as indicated by 
the superimposed traces of the current responses in the inset to Fig. 13 (91±15 pA \ ms versus 
133±15 pA \ ms control, Student’s t-test, t9 = -4.930, * P = 0.003, n = 10). On average, it 
appears that NaNP decreased PICs area by 32 %; we did not observe recovery in PICs area 
after washout. 
 
Fig. 28. NaNP treatment modulated persistent inward currents. On HMs, voltage ramps 
(from -80 to +20 mV; rate = 42 mV ⁄ s; see top scheme) induced PICs (see arrow) followed 
by a large outward current in control solution (Krebs). After NaNP application, PICs were 
depressed as indicated by the superimposed traces of the current responses in the inset.  
 
2.3 Hyperexcitability of HMs treated with NaNP 
We then investigated whether NaNP might influence HM firing properties.  
To induce repeated firing and to detect the sensitivity of spike activity to NaNP, we used 
rectangular current pulses. Current steps (300 pA for 500 ms) injected into HMs evoked 
firing as exemplified in Fig. 29 A. In control condition, this motoneuron fired 7 spikes (Vm = 
-65 mV, Fig. 29 A, top trace), while, at the end of NaNP application, the HM (tested at the 
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same Vm), responded with 19 spikes (Fig. 29 A, bottom trace). Averaging out data for 8 HMs 
showed that NaNP significantly enhanced the mean firing frequency (36±8 Hz versus 24±7 
Hz, Wilcoxon Signed Rank Test, W = -36.00, P = 0.008, n = 8, Fig. 29 B), without altering 
the slow AHP amplitude measured at the end of the 300 pA depolarizing current pulse, and at 
the same Vm before and after NaNP application (2.64±0.69 mV versus 2.85±0.59 mV control, 
Student’s t-test, t7 = -0.602, P = 0.566, n = 8, Fig. 29 C). Moreover, in all tested neurons 
bath-applied NaNP (500 µM; 30 min) increased input resistance that, on average, rose from 
135±19 MΩ to 166±23 MΩ when measured on the same neurons before and after application 
(Student’s t-test, t7 = 2.787, * P = 0.027, n = 8, Fig. 29 D). Fig. 29 E shows, for each cell, the 
change in Vm due to NaNP treatment. On a total number of 8 cells, NaNP could depolarize 5 
of them (black symbols). In the remaining three cells, the NO donor application had the 
effect of hyperpolarizing them (red symbols). 
 
Fig. 29. Changes in HM excitability induced by NaNP. (A) Example of evoked firing (300 
pA; 500 ms) in control and after NaNP application. Note the higher number of spikes in 
response to the same current injection pulse following NaNP. (B) Histograms quantify the 
HM firing frequency in control and following NaNP application (Wilcoxon Signed Rank 
Test, W = -36.00, * P = 0.008, n = 8). (C) Histograms showing no change in the AHP 
amplitude after NaNP treatment (Student’s t-test, t7 = -0.602, P = 0.566, n = 8). (D) 
Histograms quantify the rise in HM input resistance following NaNP application (Student’s t-
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test, t7 = 2.787, * P = 0.027, n = 8). (E) Scatter plot demonstrating the Vm variation 
dependent on NaNP application. Each line represents an individual neuron (black and red 
symbols for depolarizing and hyperpolarizing neurons, respectively). 
 
2.4 Hypoglossal nucleus expression of nNOS and GC 
To assess the HM sensitivity to NO, we studied, in the hypoglossal nucleus, the expression of 
brain NO synthetic enzyme and its main intracellular signal transduction mechanism, namely 
the neuronal nitric oxide synthase (nNOS) and guanylate cyclase (GC), respectively.  
Fig. 30 A, B demonstrates that the expression of nNOS was limited to a subset of cells in the 
dorsal division of the nucleus, while ventral motoneurons rarely expressed this enzyme. The 
nNOS immunoreactivity was mainly localized to neuronal perikarya and proximal processes, 
but not to the nuclear area. Out of 85±1 SMI 32 immunopositive cells counted in the whole 
hypoglossal nucleus area (mean value: 89060±1928 µm2, n = 3 rats), 18±1 co-expressed 
nNOS: 17±2 HMs were located in the dorsal part of the nucleus (identified as the HN dorsal 
area covering the 50 % of the whole HN area, evaluated, with imageJ software, for each 
analysed image), while 1±0.5 HM was located in the nucleus ventral division (Fig. 30 C). 
Since HMs are myotopically organized within the hypoglossal nucleus, the ones expressing 
nNOS are those known to innervate tongue retractor muscles (McClung & Goldberg, 1999; 
2000). Our observation is in agreement with the report of Vazquez et al. (1999) who have 
demonstrated that nNOS expression is limited to a few cells labeled in the dorsal division of 
the nucleus. 
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Fig. 30. Hypoglossal nucleus expression of nNOS. (A) Example of confocal images of 
hypoglossal nuclei stained for the nNOS enzyme (green pseudocolour, left), the motoneuron 
marker SMI 32 (red pseudocolour, centre), and the merge (right). (B) Magnifications of the 
previous images to underline the different nNOS expression pattern within the nucleus 
hypoglossus. (C) Histograms quantifying the number of cells immunopositive to SMI 32 and 
nNOS in the whole hypoglossal nucleus, nNOS in the nucleus dorsal part, nNOS in the 
nucleus ventral part, respectively. 
 
The GC antibody recognizes a peptide corresponding to amino acids 189-207 of the 
β1 subunit of this effector enzyme. The two isoforms of GC show different cellular 
distribution in the brain (Budworth et al., 1999; Gibb & Garthwaite, 2001; Mergia et al., 
2003; Szabadits et al., 2007) and diverse location at subcellular level (Russwurm et al., 2001; 
Zabel et al., 2002; Jones et al., 2008). Unlike nNOS, the expression of GC was observed in 
the cytoplasm of all HMs, without any topographical differentiation (Fig. 31 A, B). 
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This histochemical analysis revealed that, even though only a small proportion of 
motoneurons in the dorsal hypoglossal nucleus could synthesize NO, the whole nucleus 
might be able to sense the effects of this diffusing signaling molecule because virtually all 
cells can express the enzyme GC.  
 
Fig. 31. Hypoglossal nucleus expression of GC. (A) Example of confocal images of 
hypoglossal nuclei stained for the GC enzyme (β1 subunit, green pseudocolour, left), the 
motoneuron marker SMI 32 (red pseudocolour, centre), and the merge (right). (B) 
Magnifications of the previous images to underline the GC expression pattern within the 
nucleus hypoglossus. 
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Discussion 
 
The principal finding of the present report is the characterization of the early changes of rat 
HMs transiently exposed to H2O2. This treatment generated a complex chain of events that 
included reduced network activity and enhanced HM firing. These effects were not 
accompanied by either early cell death or astroglia injury, but were associated with activation 
of the motoneuronal stress factor ATF-3. Our data suggest that acute oxidative stress induced 
a series of functional changes hitherto unreported and potentially relevant to the theory of 
oxidative damage in ALS (Turner et al., 2009; Vucic & Kiernan, 2009). Furthermore, we 
obtained a few preliminary data concerning the effects of NaNP, a NO donor, on HMs 
electrophysiological properties.  
 
1. H2O2 application as a model to investigate oxidative stress of HMs 
Although the neuropathological results obtained from human ALS autopsy cases are valuable 
and important, almost all such cases represent only the terminal stage of the disease. This 
makes it difficult to clarify how and why ALS motoneurons are impaired at each clinical 
stage from disease onset to death, and as a consequence, human autopsy cases alone yield 
little insight into potential therapies for ALS (Kato, 2008). Clinical electrophysiology data 
suggest that the ALS disease is widespread at the time of diagnosis, implying that it has been 
active and disseminated through the motor system for some time prior to presentation with 
weakness and atrophy (Swash & Ingram, 1988). This realization calls for experimental 
models that can yield important information for clarifying the early pathogenesis of ALS in 
humans (Kato, 2008). 
Current theories of ALS propose that motoneuron damage may result from oxidative stress as 
indicated by the host (>140) of SOD-1 mutations implicated in the genetic forms of ALS 
that, however, are only 10 % of all clinical cases and have generated a large number of 
mouse genetic models (Vucic & Kiernan, 2009). Such experimental studies have not 
provided a uniform theory to account for motoneuron damage and have been primarily 
conducted with mouse motoneurons. Since some experimental manipulations are difficult on 
mice because of their innate size, rat models of ALS have also been developed. Like its 
murine counterpart, the rat G93A model reproduces the major phenotype of motoneuron 
degeneration (Aoki et al., 2005), although spinal rather than brainstem motoneurons are 
primarily affected (Lladó et al., 2006).  
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Since the vast majority of ALS cases are sporadic and presumably imply an environmental 
toxic agent (Cleveland & Rothstein, 2001), we wished to understand how rat HMs could 
respond to strong oxidative stress to identify certain mechanisms that might lead to 
motoneuron degeneration. Of course, the present study suffers from certain intrinsic 
limitations like the use of neonatal motoneurons and the inability to follow up the long term 
evolution of damage because brain slices have restricted survival in vitro. Nevertheless, the 
present results offer a novel insight into the early events of oxidative stress and could 
contribute to identify certain mechanisms that might lead to motoneuron degeneration. 
 
2. Early consequences of H2O2 application on synaptic transmission and 
HM excitability 
H2O2 evoked a slowly developing inward current (depolarization) with input resistance rise 
and relatively poor recovery on washout. Regardless of the application of receptor or channel 
blockers, and of voltage or current clamp recording, we consistently found a significant rise 
in input resistance evoked by H2O2. This observation implied depression of a leak 
background current that was not inhibited by intracellular Cs+ contained in the patch pipette. 
Previous studies indicated that rat motoneurons possess a background K+ current rather 
resistant to Cs+ (Fisher & Nistri, 1993) subsequently identified as a member of the TASK 
family of K+ channels, whose main constituent, namely TASK-1, is expressed chiefly by 
motoneurons (Talley et al., 2000; Bayliss et al., 2001). In accordance with this notion, in the 
presence of hydrogen peroxide, the current response had a very negative extrapolated 
reversal potential with linear I/V plot, consistent with the properties of TASK-1. It is likely 
that the larger input resistance of motoneurons contributed to their higher excitability.  
This phenomenon, accompanied by a significant reduction in the frequency of sPSCs, 
suggested a complex scenario that might have comprised changes in the release of various 
transmitters. To examine this issue more directly, we used TTX to investigate how miniature 
synaptic events responded to H2O2. Blocking fast glutamatergic transmission with APV and 
CNQX did not prevent the effects by H2O2 on baseline current or input resistance, and 
revealed a paradoxical rise in the frequency of inhibitory synaptic events that are known to 
be mediated by glycine and GABA (Donato & Nistri, 2000) whose reversal potential, in our 
recording conditions, was ≈ 0 mV (see also Donato & Nistri, 2000). 
Since H2O2 is known to raise intracellular free Ca2+ (Zheng & Shen, 2005; Takahashi et al., 
2007; Gerich et al., 2009) and its action was mimicked by thapsigargin, our data accord with 
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the potentiation by H2O2 of GABAergic miniature event frequency via increased intracellular 
free Ca2+ (Takahashi et al., 2007). Furthermore, Hahm et al. (2010) have found that H2O2 
increases GABAergic mIPSC frequency through the cAMP protein kinase A (PKA)-
dependent pathway in isolated cerebral cortical neurons of the rat. Neurochemical 
experiments on rat hippocampal slices also demonstrate that H2O2 markedly potentiates 
GABA release (Saransaari & Oja, 2008). Blocking inhibitory synaptic transmission with 
strychnine and bicuculline eliminated the effects by H2O2 on motoneuron baseline current, 
yet enabled us to observe a significant increase in glutamatergic miniature events as well as 
in input resistance. Thus, H2O2 seemingly facilitated release of glutamate, GABA and 
glycine, indicating a presynaptic origin for this process at the level of network-independent 
release.  
While our data indicate enhancement of miniature event frequency, they contrast with the 
observed fall in network-mediated synaptic events. The latter finding has been reported for 
hippocampal pyramidal neurons on which H2O2 depresses electrically-evoked excitatory and 
inhibitory synaptic potentials (Pellmar, 1987). This discrepancy led us to investigate changes 
in voltage dependent currents that may be responsible for changes in neuronal excitability. 
 
3. Raised HM firing despite PIC suppression by H2O2  
Previous studies have shown that mammalian spinal neuron excitability is largely mediated 
by PICs that comprised PIC(Na) (Darbon et al., 2004; Harvey et al., 2006; Zhong et al., 
2007) and PIC(Ca) (Li & Bennett, 2007). These currents are also expressed by neonatal rat 
HMs (Lamanauskas & Nistri, 2008) and are found to be potentiated in the mouse SOD1G93A 
model (van Zundert et al., 2008), in analogy with SOD1G93A spinal motoneurons in culture 
(Kuo et al., 2005). It is, however, interesting that spinal motoneurons of the SOD1G85R model 
display less excitability than wildtype cells (Bories et al., 2007), even if their repeated firing 
is proposed to be regulated by PIC(Na) (Amendola et al., 2007). The same group (Pambo-
Pambo et al., 2009) has demonstrated that SOD1G93A low expressor mutant is hyperexcitable 
to current pulses, whereas SOD1G93A low expressor and SOD1G85R models have a lower gain 
with current ramps stimulation. Changes in the threshold and intensities of Na+ and Ca2+ 
persistent inward currents have been also observed. SOD1G93A low expressor mutants show 
reduced total persistent inward currents compared with control motoneurons.  
In the present study we observed that H2O2 induced a larger reduction of PIC(Ca) (79 %) 
than of PIC(Na) (38 %) without threshold alteration. Notwithstanding the impaired amplitude 
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of PICs by H2O2, we detected accelerated firing rates of HMs with strong inhibition of the 
AHP. Since H2O2 only partly depressed PIC(Na), this effect would not be sufficient to 
change excitability because nearly complete block of PIC(Na) is necessary for strong 
depression of HM firing (Lamanauskas & Nistri, 2008).  
Blocking Ca2+ channels often prolongs the action potential and raises neuronal excitability, 
an effect opposite to the one expected from blocking the entry of positively charged ions 
(Bean, 2007). This reflects powerful and rapid coupling of Ca2+ entry to the activation of 
Ca2+-activated K+ channels, so that the net effect of blocking Ca2+ influx is to inhibit a net 
outward current and, therefore, to increase excitability (Bean, 2007). In accordance with this 
notion, we suggest that H2O2 enhanced firing because it largely depressed Ca2+ influx, as 
shown by the decreased in PIC(Ca), important for the activation of the Ca2+ dependent K+ 
conductances underlying the AHP (Umemiya & Berger, 1994; Lape & Nistri, 1999; Li & 
Bennett, 2007). These effects were apparently distinct from the facilitation by H2O2 of Ca2+ 
release from presynaptic intracellular stores (as discussed above), a phenomenon that 
developed in the absence of firing following TTX application. 
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Fig. 32. Scheme summarizing H2O2 effects on hypoglossal motoneuron (HM) 
electrophysiological properties. (A) H2O2 enhanced the frequency of both excitatory and 
inhibitory miniature events presumably via increased intracellular free Ca2+ in 
premotoneuron synaptic terminals. (B) H2O2 augmented HM input resistance possibly by 
depressing the leak background current mediated by TASK-1, a member of the TASK family 
of K+ channels, chiefly expressed by motoneurons. (C) H2O2 induced a larger reduction of 
PIC(Ca) (79 %, mediated by V-activated Ca2+ channels) than of PIC(Na) (38 %, mediated by 
V-activated Na+ channels). Thus, the lessened Ca2+ influx had a negative effect on the 
activation of Ca2+ dependent K+ conductances underlying the AHP. Inhibition of such a net 
outward current, together with the HM larger input resistance (see B), is likely to contribute 
to HM higher excitability (D). 
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4. Early motoneuron damage by H2O2  
We next explored whether, as a result of exposure to H2O2, HMs were damaged. We first 
ascertained that this treatment was actually accompanied by a significant rise in intracellular 
oxidative processes. It is interesting that advanced oxidation protein products are higher in 
the CSF of ALS patients, with concurrent decrease in antioxidant capacity, compared with 
controls with other neurological diseases (Siciliano et al., 2007). Furthermore, we counted 
the number of PI positive cells or SMI 32 positive HMs to find out if there had been a rapid 
and extensive cell death.  Our results indicated that there was no change in the number of 
motoneurons in the slices, suggesting that oxidative stress, albeit of strong intensity, did not 
produce early motoneuronal death. It was, however, apparent that the H2O2 application had 
evoked an important reaction in HMs because of the large increase in their 
immunocytochemical expression of ATF-3.   
ATF-3 is a transcription factor induced by harmful extracellular stimuli that trigger 
intracellular kinase activity responsible for neosynthesis of ATF-3 and its translocation to the 
cell nucleus where it can be observed after neuronal lesion (Tsujino et al., 2000; Nakagomi et 
al., 2003; Lindwall et al., 2004). ATF-3 has a Janus-like function subserving either damage 
repair or degeneration depending on the nature of the insult (Tsujino et al., 2000; Nakagomi 
et al., 2003; Vlug et al., 2005). In SODG93A mouse motoneurons ATF-3 is strongly expressed 
prior to neurodegeneration (Vlug et al., 2005). We suggest that the ATF-3 signal observed in 
the present study was an index of initial distress of motoneuron subsequent to H2O2 
treatment. Its cytoplasmic location was probably due to the fact that the DNA transcriptional 
effects of ATF-3 require its de novo protein synthesis in the cytosol (Lindwall et al., 2004).       
In conclusion, most research into neurophysiological biomarkers of ALS has focussed on the 
development of surrogate markers of motor unit loss (Turner et al., 2009). 
Electrophysiological studies of early stage ALS have shown increased motoneuron 
excitability attributed to dysfunction of motor cortex (Turner et al., 2009). However, lower 
motoneuron hyperexcitability is also an important feature of the disease presentation. If we 
assume that oxidative stress may be a significant contributor to ALS pathology (Turner et al., 
2009; Vucic & Kiernan, 2009), our current results suggest that an oxidative stress, even when 
transient, can render brainstem motoneuron hyperexcitable through a combination of 
enhanced input resistance and firing rate, a condition accompanied by ATF-3 activation.   
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5. H2O2 effects on astroglia 
Although progressive paralysis in ALS arises from degeneration and death of motoneurons, 
evidence from several directions has converged to demonstrate that toxicity is non-cell-
autonomous, but it derives from damage also developed within cell types other than 
motoneurons (Clement et al., 2003; Boillée et al., 2006). In the postnatal rat central nervous 
system the main astrocyte type is the protoplasmic one (Miller & Raff, 1984) which is readily 
labeled by immunostaining its Ca2+-binding protein S100B (Cocchia, 1981; Didier et al., 
1986). S100B is involved in a variety of intracellular and extracellular activities (Donato, 
2001), and, in particular, it can exert beneficial (neurotrophic) or detrimental (neurotoxic) 
effects on surrounding glia and neurons depending on its concentration (Rothermundt et al., 
2003). Changes in S100B immunoreactivity have, in fact, been associated with brain damage 
and degenerative brain diseases (Rothermundt et al., 2003; Blackburn et al., 2009) including 
ALS: indeed, it is interesting that S100B immunoreactivity has been found to be upregulated 
in astrocytes in the spinal cord of ALS patients (Migheli et al., 1999). The present study 
observed that 30 min application of H2O2 did not change S100B immunoreactivity in the 
nucleus hypoglossus; it is likely that the exposure time of brainstem slices to the oxidative 
challenge was not prolonged enough to produce damage to astroglia in this nucleus. In 
keeping with this view, Zagami et al. (2009), using primary cultures of neurons and 
astrocytes treated with 300 µM H2O2, have demonstrated that reducing cell viability by 50 % 
(considering 100 % as the maximal effect obtained) requires 47 min of incubation. More 
recently, our lab has reported that, in spinal cord preparations subjected for 1 h to a 
“pathological medium” (PM, i.e. hypoxic / aglycemic solution containing toxic radicals), 
active caspase-3 positive cells are identified almost exclusively in the ventrolateral white 
matter 2 h after washout of PM and are found to overlap with those positive for GFAP or O4, 
suggesting late-onset of apoptotic cell death of white matter fibrous astrocytes and 
oligodendrocytes. Furthermore, in PM treated spinal cords, pyknosis starts to occur in the 
white matter 2 h after treatment (Kuzhandaivel et al., 2010). Thus, following hypoxic-
dysmetabolic perturbations, white matter glial cells, especially fibrous astrocytes (GFAP+) 
and oligodendrocytes (O4+), are more vulnerable than neurons and astroglial cells (S100B+) 
of the gray matter, and signs of cell-death commitment begin to appear 2 h after PM 
application (Kuzhandaivel et al., 2010). 
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6. NaNP influenced HM synaptic transmission and excitability: 
preliminary considerations 
Our immunohistochemical analysis of the nucleus hypoglossus revealed that the expression 
of nNOS is limited to a subset of cells in the dorsal division of the nucleus, while ventral 
motoneurons rarely expresse this enzyme, as previously reported by Vazquez et al. (1999). 
Nonetheless, the whole nucleus motoneuronal population expressed the enzyme GC, thus 
rendering HMs able to sense the effects of NO. 
In order to generate NO, we exposed brainstem slices to 500 µM NaNP; this dose, 
accordingly to Southam and Garthwaite (1991), should correspond to a concentration in the 
recording chamber of 0.05 µM, large enough to evoke toxic effects typically observed with 
near-micromolar concentrations (Dawson et al., 1993; Liu & Martin, 2001; Hall et al., 2009). 
The application of the NO donor NaNP caused the onset of an outward current accompanied 
by an increase in input resistance. This result suggested the depression of a sustained inward 
conductance active at resting Vm. Previous studies have indicated that NO decreases 
GABAAR function (Robello et al., 1996; Wexler et al., 1998; Wall, 2003). Robello et al. 
(1996) have demonstrated, both in adult rat cerebral cortex and in neonatal rat cerebellar 
granule cells, a reduction in GABA-stimulated Cl- influx by treatment with NO chemical 
donors. Wexler et al. (1998) have reported that NO analogs decrease GABA-gated currents 
in cultured retinal amacrine cells via coactivation of cGMP-dependent kinase and 
phosphodiesterase. Finally, following a reduction in the concentration of endogenous NO in 
adult rat cerebellum, Wall (2003) has observed effects consistent with enhanced granule cell 
GABAAR activation.  
In the present study, spontaneous synaptic events occurred at lower rate in the presence of 
NaNP, a phenomenon most likely due to the decreased activity of premotoneurons. Sunico et 
al. (2010) have recently demonstrated that gain in neuronal NO signaling (obtained through 
either nNOS retrograde transfection or 6 h exposure to a long half-life NO donor) is 
sufficient to induce excitatory and inhibitory synapse withdrawal and to reduce evoked 
EPSPs in neonatal HMs via paracrine action on presynaptic structure. Thus, the result 
obtained might be the first step of a complex chain of events leading to synapse detachment. 
Further studies will be required to clarify the mode of action of NO on HMs baseline current 
and network premotoneurons. 
We were also interested in clarifying NO effects on voltage-activated conductances. It has 
been previously reported that NO could modulate persistent Na+ conductances. Sawada et al. 
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(1995) have studied the effects of micropressure-ejected NO generators on the membrane of 
identified neurons in the Aplysia kurodai abdominal ganglion; they have demonstrated the 
induction of a slow inward current associated with an increase in Na+ conductance mediated 
by a rise in the intracellular level of cGMP. The effects of NO donors on persistent Na+ 
current have been examined also in rat hippocampal neurons (Hammarström & Gage, 1999); 
in particular, these authors have reported an increase (by 60-80 %) within a few minutes of 
exposure to either NaNP or S-nitroso-N-acetyl-DL-penicillamine (SNAP). The amplitude of 
the transient Na+ current is not changed significantly by NO donors, indicating a selective 
effect on the persistent component. Our experimental data revealed that NaNP decreased 
total PICs area, mediated by both Na+ and Ca2+ (Crill, 1996; Russo & Hounsgaard, 1999), by 
32 %. Further investigations are needed to elucidate the specific contribution of the Mn2+-
sensitive component – PIC(Ca) – and the TTX-sensitive component – PIC(Na) – to the 
observed reduction. 
In current clamp experiments, we consistently found a significant rise in input resistance 
evoked by NaNP, together with enhanced spike firing and unchanged AHP amplitude. 
Previous studies have showed a positive regulation of the firing rate exerted by NO donors, 
both in locus coeruleus neurons (Xu et al., 1998) and in the vagal dorsal motor nucleus 
(Travagli & Gillis, 1994). Despite the impairing action of NaNP on PICs, known to be 
involved in mammalian neuron excitability (Darbon et al., 2004; Harvey et al., 2006; Zhong 
et al., 2007), it is likely that the larger input resistance of motoneurons contributed to their 
higher excitability and compensated for the PICs area decrease. Furthermore, on a total 
number of 8 cells recorded under current clamp configuration, 5 HMs (Vm < -60 mV) 
depolarized following NaNP application, while the remaining 3 cells (Vm > -60 mV) 
hyperpolarized, indicating that motoneurons are not a homogeneous population with regard 
to their Vm response to NO. The most parsimonious interpretation is that the leak 
conductance modulated by NaNP might have a reversal potential in the range of the recorded 
cells Vm. NO donors are known to depolarize different neuronal preparation: adult mouse 
locus coeruleus neurons (Pineda et al., 1996), adult rat type II paraventricular nucleus 
neurons (Bains & Ferguson, 1997), adult guinea pig trigeminal motoneurons (Abudara et al., 
2002), juvenile rat and mouse optic nerve (Garthwaite et al., 2006), rat P6-P9 hypoglossal 
motoneurons (González-Forero et al., 2007; Montero et al., 2008). This action is proposed to 
be exerted through an NO action on different conductances, namely the hyperpolarization-
activated cationic current (Ih), hyperpolarization-activated cyclic nucleotide-gated channels 
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(HCN), and TASK-like K+ conductances (Abudara et al., 2002; Garthwaite et al., 2006; 
González-Forero et al., 2007; Montero et al., 2008). Unlike the previous observations, Xu et 
al. (1998) have reported that NO donors caused both hyperpolarization and depolarization in 
locus coeruleus neurons. 
 
Our data concerning the effects of NO on HMs are preliminary; from an electrophysiological 
point of view, they will need experiments performed in the presence of synaptic transmission 
blockers, and of selective blockers of PIC(Na) and PIC(Ca). Moreover, 
immunohistochemical analysis will be required to investigate the potential toxic effect of 500 
µM NaNP on HMs and astroglia. The present results revealed, however, that the NO effect 
on HMs was different from the one exerted by hydrogen peroxide, suggesting that oxidative 
and nitrosative damage might occur through distinct mechanisms of action, even if HMs 
ultimately show enhanced firing in either case. Future studies will be necessary to find out if 
motoneuron injury induced by these two processes might evolve with different time course 
and outcome. 
Our report left, thus, (1) to be clarified what conductance/s is/are involved in the reported 
effect of NO on HM baseline current/membrane potential; (2) to be evaluated the mechanism 
through which NaNP modify motoneuronal excitability; and (3) to be investigated the 
nitrosative stress consequences on hypoglossal nucleus cell populations, in terms of damage 
and survival. 
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